Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0044237 | 0.00000 | 1.63947 | 772 | 989 | 9199 | cellular metabolic process |
| GO:0008152 | 0.00000 | 1.62821 | 867 | 1084 | 10337 | metabolic process |
| GO:0006518 | 0.00000 | 2.78424 | 64 | 148 | 758 | peptide metabolic process |
| GO:0033108 | 0.00000 | 11.73312 | 6 | 38 | 74 | mitochondrial respiratory chain complex assembly |
| GO:0006807 | 0.00000 | 1.57794 | 736 | 934 | 8771 | nitrogen compound metabolic process |
| GO:0007005 | 0.00000 | 3.37058 | 37 | 102 | 445 | mitochondrion organization |
| GO:0034641 | 0.00000 | 1.63733 | 456 | 630 | 5435 | cellular nitrogen compound metabolic process |
| GO:0071840 | 0.00000 | 1.58898 | 512 | 685 | 6096 | cellular component organization or biogenesis |
| GO:0071704 | 0.00000 | 1.51635 | 826 | 1010 | 9839 | organic substance metabolic process |
| GO:0016043 | 0.00000 | 1.56747 | 498 | 663 | 5929 | cellular component organization |
| GO:0043043 | 0.00000 | 2.72276 | 53 | 121 | 626 | peptide biosynthetic process |
| GO:0044238 | 0.00000 | 1.51017 | 780 | 961 | 9296 | primary metabolic process |
| GO:0043603 | 0.00000 | 2.31506 | 81 | 163 | 970 | cellular amide metabolic process |
| GO:0006412 | 0.00000 | 2.72646 | 51 | 117 | 604 | translation |
| GO:1901564 | 0.00000 | 1.54057 | 514 | 676 | 6130 | organonitrogen compound metabolic process |
| GO:1901566 | 0.00000 | 1.95975 | 129 | 223 | 1539 | organonitrogen compound biosynthetic process |
| GO:0010257 | 0.00000 | 15.34704 | 4 | 25 | 43 | NADH dehydrogenase complex assembly |
| GO:0032981 | 0.00000 | 15.34704 | 4 | 25 | 43 | mitochondrial respiratory chain complex I assembly |
| GO:0043604 | 0.00000 | 2.44337 | 61 | 128 | 723 | amide biosynthetic process |
| GO:0009987 | 0.00000 | 1.52622 | 1310 | 1465 | 15608 | cellular process |
| GO:0044260 | 0.00000 | 1.48762 | 585 | 743 | 6974 | cellular macromolecule metabolic process |
| GO:0034622 | 0.00000 | 2.16652 | 83 | 157 | 984 | cellular protein-containing complex assembly |
| GO:0044085 | 0.00000 | 1.64818 | 247 | 361 | 2940 | cellular component biogenesis |
| GO:0009058 | 0.00000 | 1.50762 | 420 | 555 | 5000 | biosynthetic process |
| GO:0043933 | 0.00000 | 1.77556 | 160 | 254 | 1910 | protein-containing complex subunit organization |
| GO:0009144 | 0.00000 | 3.44532 | 22 | 62 | 263 | purine nucleoside triphosphate metabolic process |
| GO:0065003 | 0.00000 | 1.80586 | 142 | 229 | 1690 | protein-containing complex assembly |
| GO:0009141 | 0.00000 | 3.31063 | 23 | 64 | 280 | nucleoside triphosphate metabolic process |
| GO:0009205 | 0.00000 | 3.45197 | 21 | 60 | 254 | purine ribonucleoside triphosphate metabolic process |
| GO:0009123 | 0.00000 | 3.34450 | 23 | 62 | 269 | nucleoside monophosphate metabolic process |
| GO:0022607 | 0.00000 | 1.62845 | 228 | 333 | 2723 | cellular component assembly |
| GO:1901576 | 0.00000 | 1.48698 | 412 | 541 | 4910 | organic substance biosynthetic process |
| GO:0009199 | 0.00000 | 3.38159 | 22 | 60 | 258 | ribonucleoside triphosphate metabolic process |
| GO:0044249 | 0.00000 | 1.48576 | 405 | 532 | 4824 | cellular biosynthetic process |
| GO:0009167 | 0.00000 | 3.37509 | 21 | 59 | 254 | purine ribonucleoside monophosphate metabolic process |
| GO:0009126 | 0.00000 | 3.35771 | 21 | 59 | 255 | purine nucleoside monophosphate metabolic process |
| GO:0046034 | 0.00000 | 3.52205 | 19 | 55 | 229 | ATP metabolic process |
| GO:0009161 | 0.00000 | 3.30662 | 22 | 59 | 258 | ribonucleoside monophosphate metabolic process |
| GO:0043170 | 0.00000 | 1.40247 | 701 | 845 | 8357 | macromolecule metabolic process |
| GO:0042775 | 0.00000 | 8.02643 | 5 | 24 | 57 | mitochondrial ATP synthesis coupled electron transport |
| GO:0044271 | 0.00000 | 1.49223 | 329 | 440 | 3918 | cellular nitrogen compound biosynthetic process |
| GO:0010467 | 0.00000 | 1.45513 | 395 | 513 | 4707 | gene expression |
| GO:0044267 | 0.00000 | 1.45764 | 377 | 492 | 4494 | cellular protein metabolic process |
| GO:0006119 | 0.00000 | 5.52839 | 8 | 30 | 90 | oxidative phosphorylation |
| GO:0022900 | 0.00000 | 5.62324 | 7 | 29 | 86 | electron transport chain |
| GO:0042773 | 0.00000 | 7.15736 | 5 | 24 | 61 | ATP synthesis coupled electron transport |
| GO:0006163 | 0.00000 | 2.49274 | 36 | 78 | 428 | purine nucleotide metabolic process |
| GO:0009150 | 0.00000 | 2.51301 | 34 | 74 | 403 | purine ribonucleotide metabolic process |
| GO:0022904 | 0.00000 | 5.62576 | 7 | 27 | 80 | respiratory electron transport chain |
| GO:0019538 | 0.00000 | 1.40318 | 442 | 556 | 5268 | protein metabolic process |
| GO:0009117 | 0.00000 | 2.23496 | 45 | 89 | 535 | nucleotide metabolic process |
| GO:0006753 | 0.00000 | 2.22058 | 46 | 90 | 544 | nucleoside phosphate metabolic process |
| GO:0009259 | 0.00000 | 2.43772 | 35 | 74 | 413 | ribonucleotide metabolic process |
| GO:0006996 | 0.00000 | 1.46575 | 293 | 390 | 3492 | organelle organization |
| GO:1901135 | 0.00000 | 1.88824 | 80 | 136 | 949 | carbohydrate derivative metabolic process |
| GO:0019693 | 0.00000 | 2.39836 | 36 | 76 | 430 | ribose phosphate metabolic process |
| GO:0009059 | 0.00000 | 1.43285 | 338 | 439 | 4028 | macromolecule biosynthetic process |
| GO:0072521 | 0.00000 | 2.30454 | 39 | 80 | 468 | purine-containing compound metabolic process |
| GO:0055114 | 0.00000 | 1.87038 | 79 | 134 | 942 | oxidation-reduction process |
| GO:0044281 | 0.00000 | 1.63331 | 143 | 214 | 1708 | small molecule metabolic process |
| GO:0055086 | 0.00000 | 2.09078 | 51 | 95 | 604 | nucleobase-containing small molecule metabolic process |
| GO:0045333 | 0.00000 | 3.53565 | 13 | 38 | 157 | cellular respiration |
| GO:0006139 | 0.00000 | 1.38230 | 396 | 497 | 4720 | nucleobase-containing compound metabolic process |
| GO:0034645 | 0.00000 | 1.40786 | 330 | 424 | 3933 | cellular macromolecule biosynthetic process |
| GO:0006725 | 0.00000 | 1.37029 | 412 | 513 | 4913 | cellular aromatic compound metabolic process |
| GO:0017144 | 0.00000 | 1.95304 | 58 | 103 | 694 | drug metabolic process |
| GO:0032970 | 0.00000 | 2.35533 | 32 | 66 | 378 | regulation of actin filament-based process |
| GO:0048523 | 0.00000 | 1.37540 | 386 | 484 | 4605 | negative regulation of cellular process |
| GO:0051179 | 0.00000 | 1.34450 | 486 | 591 | 5794 | localization |
| GO:0048519 | 0.00000 | 1.35641 | 435 | 536 | 5186 | negative regulation of biological process |
| GO:0051270 | 0.00000 | 1.77117 | 83 | 135 | 993 | regulation of cellular component movement |
| GO:0046483 | 0.00000 | 1.36364 | 407 | 505 | 4848 | heterocycle metabolic process |
| GO:1901360 | 0.00000 | 1.35488 | 428 | 527 | 5097 | organic cyclic compound metabolic process |
| GO:0007229 | 0.00000 | 4.51948 | 7 | 25 | 86 | integrin-mediated signaling pathway |
| GO:0051128 | 0.00000 | 1.47116 | 211 | 286 | 2513 | regulation of cellular component organization |
| GO:0006928 | 0.00000 | 1.53033 | 162 | 229 | 1932 | movement of cell or subcellular component |
| GO:0030029 | 0.00000 | 1.89071 | 60 | 104 | 720 | actin filament-based process |
| GO:0001558 | 0.00000 | 2.19054 | 36 | 71 | 432 | regulation of cell growth |
| GO:0019637 | 0.00000 | 1.76566 | 77 | 125 | 920 | organophosphate metabolic process |
| GO:0009966 | 0.00000 | 1.44183 | 228 | 303 | 2712 | regulation of signal transduction |
| GO:0010941 | 0.00000 | 1.55235 | 141 | 202 | 1677 | regulation of cell death |
| GO:0032879 | 0.00000 | 1.42965 | 231 | 305 | 2749 | regulation of localization |
| GO:0016477 | 0.00000 | 1.59594 | 117 | 173 | 1397 | cell migration |
| GO:0048870 | 0.00000 | 1.56536 | 129 | 187 | 1538 | cell motility |
| GO:0051674 | 0.00000 | 1.56536 | 129 | 187 | 1538 | localization of cell |
| GO:0008219 | 0.00000 | 1.48891 | 173 | 238 | 2056 | cell death |
| GO:0006950 | 0.00000 | 1.38279 | 295 | 376 | 3512 | response to stress |
| GO:0006120 | 0.00000 | 13.41356 | 2 | 11 | 20 | mitochondrial electron transport, NADH to ubiquinone |
| GO:0043067 | 0.00000 | 1.56352 | 128 | 186 | 1531 | regulation of programmed cell death |
| GO:0051239 | 0.00000 | 1.39769 | 266 | 344 | 3173 | regulation of multicellular organismal process |
| GO:2000145 | 0.00000 | 1.73862 | 76 | 122 | 909 | regulation of cell motility |
| GO:0060548 | 0.00000 | 1.66910 | 90 | 138 | 1067 | negative regulation of cell death |
| GO:0016049 | 0.00000 | 1.99751 | 43 | 78 | 513 | cell growth |
| GO:0012501 | 0.00000 | 1.49481 | 159 | 221 | 1898 | programmed cell death |
| GO:0040012 | 0.00000 | 1.68892 | 83 | 129 | 986 | regulation of locomotion |
| GO:1902600 | 0.00000 | 4.00699 | 8 | 24 | 90 | proton transmembrane transport |
| GO:1990542 | 0.00000 | 4.78554 | 6 | 20 | 66 | mitochondrial transmembrane transport |
| GO:0030334 | 0.00000 | 1.73692 | 72 | 116 | 864 | regulation of cell migration |
| GO:0018158 | 0.00000 | 19.73787 | 1 | 9 | 14 | protein oxidation |
| GO:0072359 | 0.00000 | 1.63989 | 94 | 142 | 1115 | circulatory system development |
| GO:0042981 | 0.00000 | 1.54481 | 127 | 182 | 1512 | regulation of apoptotic process |
| GO:0006793 | 0.00000 | 1.39719 | 245 | 317 | 2914 | phosphorus metabolic process |
| GO:0006796 | 0.00000 | 1.39832 | 243 | 315 | 2893 | phosphate-containing compound metabolic process |
| GO:0006915 | 0.00000 | 1.48852 | 156 | 216 | 1860 | apoptotic process |
| GO:0009967 | 0.00000 | 1.54456 | 124 | 178 | 1478 | positive regulation of signal transduction |
| GO:0040011 | 0.00000 | 1.48910 | 146 | 203 | 1744 | locomotion |
| GO:0097435 | 0.00000 | 1.80413 | 56 | 93 | 668 | supramolecular fiber organization |
| GO:0043062 | 0.00000 | 2.28871 | 25 | 50 | 292 | extracellular structure organization |
| GO:0007007 | 0.00000 | 8.23259 | 2 | 12 | 28 | inner mitochondrial membrane organization |
| GO:0048583 | 0.00000 | 1.33639 | 315 | 391 | 3755 | regulation of response to stimulus |
| GO:0006839 | 0.00000 | 2.80151 | 14 | 34 | 168 | mitochondrial transport |
| GO:0032543 | 0.00000 | 4.23216 | 6 | 20 | 72 | mitochondrial translation |
| GO:0010499 | 0.00000 | 9.28456 | 2 | 11 | 24 | proteasomal ubiquitin-independent protein catabolic process |
| GO:0015980 | 0.00000 | 2.40987 | 21 | 44 | 246 | energy derivation by oxidation of organic compounds |
| GO:0072593 | 0.00000 | 2.30057 | 23 | 48 | 279 | reactive oxygen species metabolic process |
| GO:0000028 | 0.00000 | 10.96856 | 2 | 10 | 20 | ribosomal small subunit assembly |
| GO:0001944 | 0.00000 | 1.73840 | 62 | 100 | 742 | vasculature development |
| GO:0030036 | 0.00000 | 1.79994 | 54 | 89 | 640 | actin cytoskeleton organization |
| GO:0030198 | 0.00000 | 2.38602 | 21 | 44 | 248 | extracellular matrix organization |
| GO:0031589 | 0.00000 | 2.18318 | 27 | 53 | 322 | cell-substrate adhesion |
| GO:0065008 | 0.00000 | 1.32348 | 332 | 408 | 3955 | regulation of biological quality |
| GO:0072358 | 0.00000 | 1.72350 | 63 | 101 | 755 | cardiovascular system development |
| GO:0032956 | 0.00000 | 2.15257 | 28 | 54 | 332 | regulation of actin cytoskeleton organization |
| GO:0015985 | 0.00000 | 9.97095 | 2 | 10 | 21 | energy coupled proton transport, down electrochemical gradient |
| GO:0015986 | 0.00000 | 9.97095 | 2 | 10 | 21 | ATP synthesis coupled proton transport |
| GO:0006091 | 0.00000 | 2.08269 | 30 | 56 | 354 | generation of precursor metabolites and energy |
| GO:0043069 | 0.00000 | 1.61051 | 81 | 121 | 961 | negative regulation of programmed cell death |
| GO:0140053 | 0.00000 | 3.42182 | 8 | 23 | 97 | mitochondrial gene expression |
| GO:0006810 | 0.00000 | 1.29948 | 361 | 436 | 4298 | transport |
| GO:0032535 | 0.00001 | 1.98569 | 33 | 60 | 395 | regulation of cellular component size |
| GO:0015988 | 0.00001 | 6.58483 | 3 | 12 | 32 | energy coupled proton transmembrane transport, against electrochemical gradient |
| GO:0007015 | 0.00001 | 1.97969 | 33 | 60 | 396 | actin filament organization |
| GO:0040017 | 0.00001 | 1.78973 | 48 | 80 | 577 | positive regulation of locomotion |
| GO:0016310 | 0.00001 | 1.39862 | 180 | 236 | 2144 | phosphorylation |
| GO:0097190 | 0.00001 | 1.77072 | 50 | 82 | 597 | apoptotic signaling pathway |
| GO:0051272 | 0.00001 | 1.79486 | 47 | 78 | 561 | positive regulation of cellular component movement |
| GO:0023051 | 0.00001 | 1.32480 | 275 | 341 | 3277 | regulation of signaling |
| GO:0110053 | 0.00001 | 2.25250 | 21 | 43 | 254 | regulation of actin filament organization |
| GO:0030335 | 0.00001 | 1.81843 | 44 | 74 | 526 | positive regulation of cell migration |
| GO:0002181 | 0.00001 | 3.50066 | 7 | 21 | 87 | cytoplasmic translation |
| GO:2000147 | 0.00001 | 1.80033 | 46 | 76 | 545 | positive regulation of cell motility |
| GO:0015991 | 0.00001 | 7.09863 | 2 | 11 | 28 | ATP hydrolysis coupled proton transport |
| GO:0045039 | 0.00001 | 32.85031 | 1 | 6 | 8 | protein import into mitochondrial inner membrane |
| GO:0071702 | 0.00001 | 1.36584 | 205 | 263 | 2444 | organic substance transport |
| GO:0010646 | 0.00001 | 1.32008 | 273 | 338 | 3256 | regulation of cell communication |
| GO:2001233 | 0.00001 | 1.93291 | 34 | 60 | 404 | regulation of apoptotic signaling pathway |
| GO:0051049 | 0.00001 | 1.40687 | 159 | 210 | 1892 | regulation of transport |
| GO:0043066 | 0.00001 | 1.57732 | 79 | 117 | 945 | negative regulation of apoptotic process |
| GO:0042060 | 0.00001 | 2.00901 | 29 | 53 | 345 | wound healing |
| GO:0009611 | 0.00001 | 1.83542 | 40 | 68 | 479 | response to wounding |
| GO:0030041 | 0.00001 | 2.53862 | 14 | 32 | 171 | actin filament polymerization |
| GO:0040007 | 0.00001 | 1.52835 | 93 | 133 | 1106 | growth |
| GO:0051234 | 0.00001 | 1.27646 | 372 | 443 | 4428 | establishment of localization |
| GO:0042274 | 0.00001 | 3.97479 | 5 | 17 | 64 | ribosomal small subunit biogenesis |
| GO:0017004 | 0.00002 | 6.35080 | 3 | 11 | 30 | cytochrome complex assembly |
| GO:0090662 | 0.00002 | 6.35080 | 3 | 11 | 30 | ATP hydrolysis coupled transmembrane transport |
| GO:0099131 | 0.00002 | 6.35080 | 3 | 11 | 30 | ATP hydrolysis coupled ion transmembrane transport |
| GO:0099132 | 0.00002 | 6.35080 | 3 | 11 | 30 | ATP hydrolysis coupled cation transmembrane transport |
| GO:0040008 | 0.00002 | 1.64176 | 62 | 95 | 739 | regulation of growth |
| GO:1902531 | 0.00002 | 1.41794 | 142 | 189 | 1687 | regulation of intracellular signal transduction |
| GO:0022603 | 0.00002 | 1.53023 | 88 | 127 | 1054 | regulation of anatomical structure morphogenesis |
| GO:0001503 | 0.00002 | 1.93877 | 31 | 55 | 369 | ossification |
| GO:1902903 | 0.00002 | 1.97693 | 29 | 52 | 343 | regulation of supramolecular fiber organization |
| GO:0001525 | 0.00002 | 1.78083 | 42 | 70 | 506 | angiogenesis |
| GO:0090066 | 0.00003 | 1.73779 | 46 | 75 | 554 | regulation of anatomical structure size |
| GO:0042246 | 0.00003 | 4.22381 | 5 | 15 | 54 | tissue regeneration |
| GO:0009142 | 0.00003 | 2.61375 | 12 | 28 | 146 | nucleoside triphosphate biosynthetic process |
| GO:0009124 | 0.00003 | 2.55599 | 13 | 29 | 154 | nucleoside monophosphate biosynthetic process |
| GO:0033036 | 0.00003 | 1.31814 | 237 | 294 | 2821 | macromolecule localization |
| GO:2001235 | 0.00003 | 2.41610 | 15 | 32 | 178 | positive regulation of apoptotic signaling pathway |
| GO:0001568 | 0.00003 | 1.63460 | 60 | 91 | 710 | blood vessel development |
| GO:0071705 | 0.00003 | 1.36570 | 175 | 225 | 2081 | nitrogen compound transport |
| GO:0065002 | 0.00003 | 4.11802 | 5 | 15 | 55 | intracellular protein transmembrane transport |
| GO:0006749 | 0.00003 | 4.39132 | 4 | 14 | 49 | glutathione metabolic process |
| GO:0009206 | 0.00003 | 2.70054 | 11 | 26 | 132 | purine ribonucleoside triphosphate biosynthetic process |
| GO:0009145 | 0.00004 | 2.67517 | 11 | 26 | 133 | purine nucleoside triphosphate biosynthetic process |
| GO:0031099 | 0.00004 | 2.67517 | 11 | 26 | 133 | regeneration |
| GO:0023056 | 0.00004 | 1.38388 | 153 | 200 | 1824 | positive regulation of signaling |
| GO:0071806 | 0.00004 | 4.01739 | 5 | 15 | 56 | protein transmembrane transport |
| GO:0015031 | 0.00004 | 1.39587 | 143 | 189 | 1709 | protein transport |
| GO:0009888 | 0.00004 | 1.37551 | 159 | 207 | 1899 | tissue development |
| GO:0050793 | 0.00004 | 1.31897 | 225 | 280 | 2681 | regulation of developmental process |
| GO:0010647 | 0.00005 | 1.38078 | 153 | 199 | 1818 | positive regulation of cell communication |
| GO:0061572 | 0.00005 | 2.43026 | 14 | 30 | 166 | actin filament bundle organization |
| GO:0009201 | 0.00005 | 2.62584 | 11 | 26 | 135 | ribonucleoside triphosphate biosynthetic process |
| GO:0009127 | 0.00005 | 2.56277 | 12 | 27 | 143 | purine nucleoside monophosphate biosynthetic process |
| GO:0009168 | 0.00005 | 2.56277 | 12 | 27 | 143 | purine ribonucleoside monophosphate biosynthetic process |
| GO:0048514 | 0.00005 | 1.66276 | 52 | 80 | 614 | blood vessel morphogenesis |
| GO:0001501 | 0.00005 | 1.73415 | 43 | 69 | 510 | skeletal system development |
| GO:0044743 | 0.00005 | 4.87605 | 3 | 12 | 39 | protein transmembrane import into intracellular organelle |
| GO:0051240 | 0.00006 | 1.36944 | 158 | 205 | 1887 | positive regulation of multicellular organismal process |
| GO:2001244 | 0.00006 | 3.66098 | 5 | 16 | 64 | positive regulation of intrinsic apoptotic signaling pathway |
| GO:0006626 | 0.00006 | 3.45840 | 6 | 17 | 71 | protein targeting to mitochondrion |
| GO:0009653 | 0.00006 | 1.31240 | 223 | 276 | 2652 | anatomical structure morphogenesis |
| GO:0001836 | 0.00006 | 3.83018 | 5 | 15 | 58 | release of cytochrome c from mitochondria |
| GO:2000026 | 0.00006 | 1.34493 | 179 | 228 | 2136 | regulation of multicellular organismal development |
| GO:0065009 | 0.00006 | 1.32399 | 204 | 256 | 2437 | regulation of molecular function |
| GO:0008154 | 0.00006 | 2.24441 | 17 | 34 | 201 | actin polymerization or depolymerization |
| GO:0010712 | 0.00007 | 4.04407 | 4 | 14 | 52 | regulation of collagen metabolic process |
| GO:0042254 | 0.00007 | 2.02015 | 23 | 43 | 278 | ribosome biogenesis |
| GO:0001667 | 0.00007 | 1.82258 | 34 | 57 | 403 | ameboidal-type cell migration |
| GO:0015833 | 0.00007 | 1.37646 | 147 | 192 | 1757 | peptide transport |
| GO:0051258 | 0.00007 | 2.03336 | 23 | 42 | 270 | protein polymerization |
| GO:0045184 | 0.00008 | 1.36900 | 152 | 197 | 1812 | establishment of protein localization |
| GO:0051129 | 0.00008 | 1.58960 | 61 | 91 | 727 | negative regulation of cellular component organization |
| GO:0007167 | 0.00008 | 1.53726 | 73 | 105 | 865 | enzyme linked receptor protein signaling pathway |
| GO:0060348 | 0.00008 | 2.15739 | 18 | 36 | 220 | bone development |
| GO:0009156 | 0.00009 | 2.47687 | 12 | 27 | 147 | ribonucleoside monophosphate biosynthetic process |
| GO:0051017 | 0.00009 | 2.38330 | 14 | 29 | 163 | actin filament bundle assembly |
| GO:0042886 | 0.00009 | 1.36836 | 149 | 193 | 1775 | amide transport |
| GO:0051241 | 0.00009 | 1.42909 | 110 | 148 | 1305 | negative regulation of multicellular organismal process |
| GO:0072655 | 0.00009 | 3.07064 | 7 | 19 | 87 | establishment of protein localization to mitochondrion |
| GO:0006364 | 0.00009 | 2.26015 | 16 | 32 | 188 | rRNA processing |
| GO:0072522 | 0.00009 | 2.11412 | 19 | 37 | 230 | purine-containing compound biosynthetic process |
| GO:0035556 | 0.00010 | 1.30724 | 216 | 267 | 2571 | intracellular signal transduction |
| GO:0030833 | 0.00010 | 2.40841 | 13 | 28 | 156 | regulation of actin filament polymerization |
| GO:0006811 | 0.00010 | 1.39378 | 128 | 169 | 1526 | ion transport |
| GO:0043281 | 0.00010 | 2.21740 | 17 | 33 | 197 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0007006 | 0.00010 | 2.93112 | 8 | 20 | 95 | mitochondrial membrane organization |
| GO:0008625 | 0.00011 | 3.27592 | 6 | 17 | 74 | extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0007160 | 0.00011 | 2.20386 | 17 | 33 | 198 | cell-matrix adhesion |
| GO:0006605 | 0.00011 | 2.04849 | 21 | 39 | 249 | protein targeting |
| GO:0048584 | 0.00011 | 1.32447 | 187 | 235 | 2231 | positive regulation of response to stimulus |
| GO:0022613 | 0.00012 | 1.77217 | 35 | 58 | 420 | ribonucleoprotein complex biogenesis |
| GO:0009152 | 0.00012 | 2.16595 | 17 | 34 | 207 | purine ribonucleotide biosynthetic process |
| GO:1902904 | 0.00012 | 2.46657 | 12 | 26 | 142 | negative regulation of supramolecular fiber organization |
| GO:0010648 | 0.00012 | 1.41743 | 110 | 148 | 1314 | negative regulation of cell communication |
| GO:0048585 | 0.00013 | 1.38169 | 131 | 172 | 1565 | negative regulation of response to stimulus |
| GO:0006164 | 0.00013 | 2.09982 | 19 | 36 | 225 | purine nucleotide biosynthetic process |
| GO:0006812 | 0.00013 | 1.45837 | 91 | 125 | 1080 | cation transport |
| GO:0090304 | 0.00014 | 1.24265 | 352 | 413 | 4198 | nucleic acid metabolic process |
| GO:0032963 | 0.00014 | 2.85472 | 8 | 20 | 97 | collagen metabolic process |
| GO:0008283 | 0.00014 | 1.33803 | 166 | 211 | 1981 | cell proliferation |
| GO:0023057 | 0.00014 | 1.41230 | 111 | 148 | 1318 | negative regulation of signaling |
| GO:0045185 | 0.00015 | 2.74819 | 9 | 21 | 105 | maintenance of protein location |
| GO:0006575 | 0.00015 | 2.33499 | 13 | 28 | 160 | cellular modified amino acid metabolic process |
| GO:0048646 | 0.00016 | 1.44165 | 95 | 130 | 1135 | anatomical structure formation involved in morphogenesis |
| GO:0008104 | 0.00016 | 1.29927 | 210 | 259 | 2504 | protein localization |
| GO:0006974 | 0.00017 | 1.55999 | 60 | 88 | 714 | cellular response to DNA damage stimulus |
| GO:0000302 | 0.00017 | 2.17583 | 16 | 32 | 194 | response to reactive oxygen species |
| GO:0090407 | 0.00017 | 1.70018 | 40 | 63 | 473 | organophosphate biosynthetic process |
| GO:1902255 | 0.00019 | 18.23993 | 1 | 5 | 8 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0051246 | 0.00019 | 1.28784 | 222 | 271 | 2642 | regulation of protein metabolic process |
| GO:0070585 | 0.00019 | 2.85964 | 8 | 19 | 92 | protein localization to mitochondrion |
| GO:1902533 | 0.00020 | 1.46342 | 84 | 116 | 998 | positive regulation of intracellular signal transduction |
| GO:0030038 | 0.00021 | 2.74728 | 8 | 20 | 100 | contractile actin filament bundle assembly |
| GO:0043149 | 0.00021 | 2.74728 | 8 | 20 | 100 | stress fiber assembly |
| GO:0042592 | 0.00021 | 1.33723 | 156 | 198 | 1857 | homeostatic process |
| GO:0042127 | 0.00023 | 1.35685 | 137 | 177 | 1636 | regulation of cell proliferation |
| GO:0061448 | 0.00023 | 1.93249 | 23 | 41 | 275 | connective tissue development |
| GO:0001957 | 0.00023 | 43.75745 | 0 | 4 | 5 | intramembranous ossification |
| GO:0018057 | 0.00023 | 43.75745 | 0 | 4 | 5 | peptidyl-lysine oxidation |
| GO:0036072 | 0.00023 | 43.75745 | 0 | 4 | 5 | direct ossification |
| GO:0060620 | 0.00023 | 43.75745 | 0 | 4 | 5 | regulation of cholesterol import |
| GO:2000909 | 0.00023 | 43.75745 | 0 | 4 | 5 | regulation of sterol import |
| GO:0032268 | 0.00024 | 1.29294 | 206 | 253 | 2454 | regulation of cellular protein metabolic process |
| GO:0031323 | 0.00024 | 1.21250 | 444 | 507 | 5290 | regulation of cellular metabolic process |
| GO:0070372 | 0.00025 | 1.83323 | 28 | 47 | 330 | regulation of ERK1 and ERK2 cascade |
| GO:0035239 | 0.00025 | 1.48257 | 75 | 105 | 892 | tube morphogenesis |
| GO:0033554 | 0.00025 | 1.34839 | 142 | 182 | 1692 | cellular response to stress |
| GO:0032965 | 0.00025 | 3.98837 | 4 | 12 | 45 | regulation of collagen biosynthetic process |
| GO:1903115 | 0.00025 | 3.98837 | 4 | 12 | 45 | regulation of actin filament-based movement |
| GO:1903845 | 0.00025 | 3.29287 | 5 | 15 | 65 | negative regulation of cellular response to transforming growth factor beta stimulus |
| GO:0051171 | 0.00025 | 1.21607 | 420 | 482 | 5008 | regulation of nitrogen compound metabolic process |
| GO:0042255 | 0.00025 | 3.13680 | 6 | 16 | 72 | ribosome assembly |
| GO:0098754 | 0.00026 | 4.30765 | 3 | 11 | 39 | detoxification |
| GO:0009260 | 0.00027 | 2.05797 | 18 | 34 | 216 | ribonucleotide biosynthetic process |
| GO:0032231 | 0.00028 | 2.68002 | 9 | 20 | 102 | regulation of actin filament bundle assembly |
| GO:0032940 | 0.00029 | 1.44244 | 86 | 118 | 1028 | secretion by cell |
| GO:0030307 | 0.00029 | 2.13327 | 16 | 31 | 191 | positive regulation of cell growth |
| GO:2001242 | 0.00029 | 2.23283 | 14 | 28 | 166 | regulation of intrinsic apoptotic signaling pathway |
| GO:0032101 | 0.00030 | 1.52976 | 61 | 88 | 726 | regulation of response to external stimulus |
| GO:0031032 | 0.00031 | 2.11992 | 16 | 31 | 192 | actomyosin structure organization |
| GO:2000377 | 0.00031 | 2.11992 | 16 | 31 | 192 | regulation of reactive oxygen species metabolic process |
| GO:1990748 | 0.00032 | 5.19076 | 2 | 9 | 28 | cellular detoxification |
| GO:0046456 | 0.00033 | 4.15892 | 3 | 11 | 40 | icosanoid biosynthetic process |
| GO:0090101 | 0.00033 | 2.56425 | 9 | 21 | 111 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0019222 | 0.00033 | 1.20021 | 489 | 553 | 5833 | regulation of metabolic process |
| GO:0010714 | 0.00034 | 4.56723 | 3 | 10 | 34 | positive regulation of collagen metabolic process |
| GO:1903427 | 0.00034 | 4.56723 | 3 | 10 | 34 | negative regulation of reactive oxygen species biosynthetic process |
| GO:0061383 | 0.00034 | 3.56527 | 4 | 13 | 53 | trabecula morphogenesis |
| GO:0008064 | 0.00034 | 2.17120 | 15 | 29 | 176 | regulation of actin polymerization or depolymerization |
| GO:0055085 | 0.00034 | 1.39399 | 105 | 139 | 1250 | transmembrane transport |
| GO:0002281 | 0.00035 | 9.38360 | 1 | 6 | 13 | macrophage activation involved in immune response |
| GO:0051604 | 0.00036 | 1.86761 | 24 | 42 | 290 | protein maturation |
| GO:0019220 | 0.00039 | 1.33769 | 140 | 178 | 1665 | regulation of phosphate metabolic process |
| GO:2001046 | 0.00039 | 13.67931 | 1 | 5 | 9 | positive regulation of integrin-mediated signaling pathway |
| GO:0000165 | 0.00040 | 1.48872 | 67 | 95 | 803 | MAPK cascade |
| GO:0051174 | 0.00040 | 1.33672 | 140 | 178 | 1666 | regulation of phosphorus metabolic process |
| GO:0032964 | 0.00041 | 3.47815 | 5 | 13 | 54 | collagen biosynthetic process |
| GO:0014812 | 0.00042 | 2.58507 | 9 | 20 | 105 | muscle cell migration |
| GO:0030048 | 0.00042 | 2.58507 | 9 | 20 | 105 | actin filament-based movement |
| GO:0051223 | 0.00042 | 1.53030 | 57 | 83 | 684 | regulation of protein transport |
| GO:0090087 | 0.00042 | 1.51401 | 61 | 87 | 724 | regulation of peptide transport |
| GO:0070371 | 0.00045 | 1.76564 | 29 | 48 | 348 | ERK1 and ERK2 cascade |
| GO:0009968 | 0.00045 | 1.39533 | 99 | 132 | 1185 | negative regulation of signal transduction |
| GO:0030832 | 0.00045 | 2.12747 | 15 | 29 | 179 | regulation of actin filament length |
| GO:0051493 | 0.00046 | 1.61131 | 44 | 66 | 519 | regulation of cytoskeleton organization |
| GO:0001932 | 0.00047 | 1.36220 | 117 | 152 | 1396 | regulation of protein phosphorylation |
| GO:0006754 | 0.00049 | 2.41783 | 10 | 22 | 122 | ATP biosynthetic process |
| GO:0046390 | 0.00049 | 1.98109 | 19 | 34 | 223 | ribose phosphate biosynthetic process |
| GO:0014909 | 0.00049 | 2.70773 | 8 | 18 | 91 | smooth muscle cell migration |
| GO:0006396 | 0.00049 | 1.47792 | 68 | 95 | 808 | RNA processing |
| GO:0006801 | 0.00051 | 3.20005 | 5 | 14 | 62 | superoxide metabolic process |
| GO:0051216 | 0.00051 | 2.02462 | 17 | 32 | 206 | cartilage development |
| GO:0014910 | 0.00053 | 2.78566 | 7 | 17 | 84 | regulation of smooth muscle cell migration |
| GO:0070252 | 0.00053 | 2.78566 | 7 | 17 | 84 | actin-mediated cell contraction |
| GO:0098662 | 0.00055 | 1.55402 | 50 | 74 | 601 | inorganic cation transmembrane transport |
| GO:0023014 | 0.00056 | 1.46869 | 69 | 96 | 821 | signal transduction by protein phosphorylation |
| GO:0009165 | 0.00056 | 1.86859 | 23 | 39 | 269 | nucleotide biosynthetic process |
| GO:0008380 | 0.00057 | 1.73302 | 30 | 49 | 361 | RNA splicing |
| GO:0042325 | 0.00057 | 1.34243 | 127 | 162 | 1508 | regulation of phosphorylation |
| GO:0003012 | 0.00057 | 1.71096 | 32 | 51 | 380 | muscle system process |
| GO:0046033 | 0.00058 | 8.21026 | 1 | 6 | 14 | AMP metabolic process |
| GO:0090151 | 0.00058 | 8.21026 | 1 | 6 | 14 | establishment of protein localization to mitochondrial membrane |
| GO:2001044 | 0.00058 | 8.21026 | 1 | 6 | 14 | regulation of integrin-mediated signaling pathway |
| GO:0006979 | 0.00058 | 1.69111 | 33 | 53 | 399 | response to oxidative stress |
| GO:0045785 | 0.00058 | 1.69111 | 33 | 53 | 399 | positive regulation of cell adhesion |
| GO:0071826 | 0.00059 | 1.93697 | 20 | 35 | 234 | ribonucleoprotein complex subunit organization |
| GO:0006790 | 0.00060 | 1.87747 | 22 | 38 | 261 | sulfur compound metabolic process |
| GO:0051247 | 0.00060 | 1.32948 | 136 | 172 | 1616 | positive regulation of protein metabolic process |
| GO:0030512 | 0.00060 | 3.13459 | 5 | 14 | 63 | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO:0071560 | 0.00064 | 2.01880 | 17 | 31 | 200 | cellular response to transforming growth factor beta stimulus |
| GO:0010269 | 0.00065 | 21.87770 | 1 | 4 | 6 | response to selenium ion |
| GO:0034112 | 0.00065 | 21.87770 | 1 | 4 | 6 | positive regulation of homotypic cell-cell adhesion |
| GO:0032271 | 0.00066 | 1.99002 | 18 | 32 | 209 | regulation of protein polymerization |
| GO:0016072 | 0.00067 | 1.96374 | 18 | 33 | 218 | rRNA metabolic process |
| GO:0008637 | 0.00068 | 2.46842 | 9 | 20 | 109 | apoptotic mitochondrial changes |
| GO:0051492 | 0.00070 | 2.70466 | 7 | 17 | 86 | regulation of stress fiber assembly |
| GO:0043408 | 0.00071 | 1.48183 | 63 | 88 | 746 | regulation of MAPK cascade |
| GO:0051494 | 0.00071 | 2.19886 | 13 | 25 | 150 | negative regulation of cytoskeleton organization |
| GO:0030049 | 0.00073 | 10.94293 | 1 | 5 | 10 | muscle filament sliding |
| GO:1904667 | 0.00073 | 10.94293 | 1 | 5 | 10 | negative regulation of ubiquitin protein ligase activity |
| GO:0032967 | 0.00074 | 4.48230 | 3 | 9 | 31 | positive regulation of collagen biosynthetic process |
| GO:0051649 | 0.00077 | 1.29941 | 157 | 195 | 1872 | establishment of localization in cell |
| GO:0009306 | 0.00079 | 1.55129 | 48 | 70 | 569 | protein secretion |
| GO:2000116 | 0.00079 | 1.94256 | 18 | 33 | 220 | regulation of cysteine-type endopeptidase activity |
| GO:0007166 | 0.00082 | 1.26128 | 208 | 250 | 2473 | cell surface receptor signaling pathway |
| GO:0042451 | 0.00084 | 5.89620 | 2 | 7 | 20 | purine nucleoside biosynthetic process |
| GO:0046129 | 0.00084 | 5.89620 | 2 | 7 | 20 | purine ribonucleoside biosynthetic process |
| GO:0022618 | 0.00086 | 1.93213 | 19 | 33 | 221 | ribonucleoprotein complex assembly |
| GO:0046903 | 0.00087 | 1.37131 | 99 | 130 | 1184 | secretion |
| GO:0032270 | 0.00090 | 1.32708 | 127 | 161 | 1513 | positive regulation of cellular protein metabolic process |
| GO:1901293 | 0.00092 | 1.81280 | 23 | 39 | 276 | nucleoside phosphate biosynthetic process |
| GO:0050790 | 0.00093 | 1.30105 | 150 | 186 | 1782 | regulation of catalytic activity |
| GO:0007010 | 0.00094 | 1.35407 | 107 | 139 | 1281 | cytoskeleton organization |
| GO:1903426 | 0.00096 | 2.53356 | 8 | 18 | 96 | regulation of reactive oxygen species biosynthetic process |
| GO:0001934 | 0.00096 | 1.40317 | 83 | 111 | 989 | positive regulation of protein phosphorylation |
| GO:0032368 | 0.00098 | 2.38759 | 9 | 20 | 112 | regulation of lipid transport |
| GO:0010810 | 0.00098 | 1.96033 | 17 | 31 | 205 | regulation of cell-substrate adhesion |
| GO:0071559 | 0.00098 | 1.96033 | 17 | 31 | 205 | response to transforming growth factor beta |
| GO:0090199 | 0.00099 | 3.54648 | 4 | 11 | 45 | regulation of release of cytochrome c from mitochondria |
| GO:0061035 | 0.00099 | 2.95333 | 6 | 14 | 66 | regulation of cartilage development |
| GO:0035295 | 0.00101 | 1.37865 | 93 | 122 | 1105 | tube development |
| GO:0030837 | 0.00102 | 3.09936 | 5 | 13 | 59 | negative regulation of actin filament polymerization |
| GO:0044057 | 0.00115 | 1.52623 | 48 | 70 | 577 | regulation of system process |
| GO:0098660 | 0.00115 | 1.49433 | 54 | 77 | 647 | inorganic ion transmembrane transport |
| GO:0050708 | 0.00119 | 1.59278 | 39 | 58 | 460 | regulation of protein secretion |
| GO:0032680 | 0.00121 | 2.14432 | 12 | 24 | 147 | regulation of tumor necrosis factor production |
| GO:0006220 | 0.00122 | 4.10838 | 3 | 9 | 33 | pyrimidine nucleotide metabolic process |
| GO:0110020 | 0.00123 | 2.46999 | 8 | 18 | 98 | regulation of actomyosin structure organization |
| GO:0019438 | 0.00123 | 1.21974 | 279 | 325 | 3324 | aromatic compound biosynthetic process |
| GO:0032464 | 0.00124 | 9.11868 | 1 | 5 | 11 | positive regulation of protein homooligomerization |
| GO:0035376 | 0.00124 | 9.11868 | 1 | 5 | 11 | sterol import |
| GO:0070508 | 0.00124 | 9.11868 | 1 | 5 | 11 | cholesterol import |
| GO:0052547 | 0.00126 | 1.63431 | 34 | 52 | 403 | regulation of peptidase activity |
| GO:0090288 | 0.00126 | 2.17857 | 12 | 23 | 139 | negative regulation of cellular response to growth factor stimulus |
| GO:0060343 | 0.00126 | 4.61163 | 2 | 8 | 27 | trabecula formation |
| GO:0007169 | 0.00128 | 1.54423 | 44 | 65 | 530 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0051186 | 0.00129 | 1.57358 | 40 | 60 | 481 | cofactor metabolic process |
| GO:0043065 | 0.00132 | 1.50295 | 51 | 73 | 610 | positive regulation of apoptotic process |
| GO:0009147 | 0.00133 | 6.56759 | 1 | 6 | 16 | pyrimidine nucleoside triphosphate metabolic process |
| GO:0048856 | 0.00133 | 1.17671 | 479 | 535 | 5712 | anatomical structure development |
| GO:0097193 | 0.00136 | 1.75532 | 24 | 40 | 291 | intrinsic apoptotic signaling pathway |
| GO:0048513 | 0.00136 | 1.21453 | 288 | 334 | 3430 | animal organ development |
| GO:0031333 | 0.00139 | 2.15984 | 12 | 23 | 140 | negative regulation of protein complex assembly |
| GO:0051235 | 0.00139 | 1.72659 | 26 | 42 | 310 | maintenance of location |
| GO:0006508 | 0.00140 | 1.30069 | 137 | 171 | 1636 | proteolysis |
| GO:0009438 | 0.00141 | 14.58445 | 1 | 4 | 7 | methylglyoxal metabolic process |
| GO:0071694 | 0.00141 | 14.58445 | 1 | 4 | 7 | maintenance of protein location in extracellular region |
| GO:0033627 | 0.00141 | 2.96994 | 5 | 13 | 61 | cell adhesion mediated by integrin |
| GO:0002790 | 0.00144 | 1.49723 | 51 | 73 | 612 | peptide secretion |
| GO:0042116 | 0.00144 | 2.69767 | 6 | 15 | 76 | macrophage activation |
| GO:0090092 | 0.00146 | 1.86216 | 19 | 33 | 228 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0097191 | 0.00146 | 1.86216 | 19 | 33 | 228 | extrinsic apoptotic signaling pathway |
| GO:0032640 | 0.00146 | 2.10981 | 13 | 24 | 149 | tumor necrosis factor production |
| GO:1903555 | 0.00146 | 2.10981 | 13 | 24 | 149 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0010811 | 0.00149 | 2.23923 | 10 | 21 | 124 | positive regulation of cell-substrate adhesion |
| GO:0044283 | 0.00150 | 1.49438 | 51 | 73 | 613 | small molecule biosynthetic process |
| GO:0070201 | 0.00151 | 1.45543 | 60 | 83 | 714 | regulation of establishment of protein localization |
| GO:0080090 | 0.00151 | 1.18072 | 432 | 485 | 5147 | regulation of primary metabolic process |
| GO:0018130 | 0.00153 | 1.21499 | 278 | 323 | 3313 | heterocycle biosynthetic process |
| GO:0051051 | 0.00153 | 1.54258 | 43 | 63 | 514 | negative regulation of transport |
| GO:0006140 | 0.00154 | 2.48759 | 8 | 17 | 92 | regulation of nucleotide metabolic process |
| GO:0010959 | 0.00156 | 1.61559 | 34 | 52 | 407 | regulation of metal ion transport |
| GO:0031214 | 0.00161 | 2.09296 | 13 | 24 | 150 | biomineral tissue development |
| GO:0046907 | 0.00161 | 1.30983 | 125 | 157 | 1491 | intracellular transport |
| GO:1901575 | 0.00163 | 1.28289 | 150 | 185 | 1793 | organic substance catabolic process |
| GO:0009394 | 0.00164 | 4.38084 | 2 | 8 | 28 | 2'-deoxyribonucleotide metabolic process |
| GO:0019692 | 0.00164 | 4.38084 | 2 | 8 | 28 | deoxyribose phosphate metabolic process |
| GO:1903319 | 0.00164 | 4.38084 | 2 | 8 | 28 | positive regulation of protein maturation |
| GO:0072332 | 0.00165 | 2.65404 | 6 | 15 | 77 | intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0030162 | 0.00166 | 1.45688 | 58 | 81 | 696 | regulation of proteolysis |
| GO:1901342 | 0.00169 | 1.68336 | 28 | 44 | 332 | regulation of vasculature development |
| GO:0006954 | 0.00170 | 1.47414 | 54 | 76 | 646 | inflammatory response |
| GO:0002062 | 0.00170 | 2.26398 | 10 | 20 | 117 | chondrocyte differentiation |
| GO:0043068 | 0.00171 | 1.48591 | 52 | 73 | 616 | positive regulation of programmed cell death |
| GO:1903530 | 0.00172 | 1.42297 | 67 | 91 | 799 | regulation of secretion by cell |
| GO:0032330 | 0.00174 | 3.25846 | 4 | 11 | 48 | regulation of chondrocyte differentiation |
| GO:1901362 | 0.00177 | 1.20813 | 289 | 334 | 3444 | organic cyclic compound biosynthetic process |
| GO:0009889 | 0.00179 | 1.20750 | 290 | 335 | 3456 | regulation of biosynthetic process |
| GO:0030100 | 0.00183 | 1.75045 | 23 | 38 | 277 | regulation of endocytosis |
| GO:0002791 | 0.00183 | 1.54086 | 42 | 61 | 498 | regulation of peptide secretion |
| GO:0009056 | 0.00189 | 1.25401 | 182 | 219 | 2170 | catabolic process |
| GO:0006656 | 0.00191 | 5.97026 | 1 | 6 | 17 | phosphatidylcholine biosynthetic process |
| GO:0033617 | 0.00191 | 5.97026 | 1 | 6 | 17 | mitochondrial respiratory chain complex IV assembly |
| GO:0006941 | 0.00193 | 2.06007 | 13 | 24 | 152 | striated muscle contraction |
| GO:0071706 | 0.00193 | 2.06007 | 13 | 24 | 152 | tumor necrosis factor superfamily cytokine production |
| GO:0010631 | 0.00195 | 1.74307 | 23 | 38 | 278 | epithelial cell migration |
| GO:0048731 | 0.00196 | 1.18249 | 389 | 439 | 4638 | system development |
| GO:0006123 | 0.00198 | 7.81564 | 1 | 5 | 12 | mitochondrial electron transport, cytochrome c to oxygen |
| GO:0019646 | 0.00198 | 7.81564 | 1 | 5 | 12 | aerobic electron transport chain |
| GO:0033275 | 0.00198 | 7.81564 | 1 | 5 | 12 | actin-myosin filament sliding |
| GO:0006468 | 0.00198 | 1.27602 | 151 | 185 | 1801 | protein phosphorylation |
| GO:0050673 | 0.00203 | 1.59277 | 35 | 52 | 412 | epithelial cell proliferation |
| GO:0071363 | 0.00204 | 1.48714 | 50 | 70 | 590 | cellular response to growth factor stimulus |
| GO:1901137 | 0.00204 | 1.50092 | 47 | 67 | 560 | carbohydrate derivative biosynthetic process |
| GO:0042073 | 0.00205 | 3.42413 | 4 | 10 | 42 | intraciliary transport |
| GO:0043086 | 0.00206 | 1.45419 | 56 | 78 | 671 | negative regulation of catalytic activity |
| GO:0098869 | 0.00213 | 4.78998 | 2 | 7 | 23 | cellular oxidant detoxification |
| GO:0098655 | 0.00214 | 1.45167 | 56 | 78 | 672 | cation transmembrane transport |
| GO:1903844 | 0.00219 | 2.32415 | 9 | 18 | 103 | regulation of cellular response to transforming growth factor beta stimulus |
| GO:0019243 | 0.00221 | 32.80123 | 0 | 3 | 4 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione |
| GO:0032971 | 0.00221 | 32.80123 | 0 | 3 | 4 | regulation of muscle filament sliding |
| GO:0035582 | 0.00221 | 32.80123 | 0 | 3 | 4 | sequestering of BMP in extracellular matrix |
| GO:0051596 | 0.00221 | 32.80123 | 0 | 3 | 4 | methylglyoxal catabolic process |
| GO:0061727 | 0.00221 | 32.80123 | 0 | 3 | 4 | methylglyoxal catabolic process to lactate |
| GO:0097250 | 0.00221 | 32.80123 | 0 | 3 | 4 | mitochondrial respiratory chain supercomplex assembly |
| GO:0110096 | 0.00221 | 32.80123 | 0 | 3 | 4 | cellular response to aldehyde |
| GO:1905749 | 0.00221 | 32.80123 | 0 | 3 | 4 | regulation of endosome to plasma membrane protein transport |
| GO:0090132 | 0.00222 | 1.72850 | 23 | 38 | 280 | epithelium migration |
| GO:0030155 | 0.00234 | 1.44986 | 56 | 77 | 664 | regulation of cell adhesion |
| GO:0051130 | 0.00234 | 1.32438 | 105 | 133 | 1248 | positive regulation of cellular component organization |
| GO:0050919 | 0.00237 | 3.65138 | 3 | 9 | 36 | negative chemotaxis |
| GO:1903409 | 0.00239 | 2.24255 | 9 | 19 | 112 | reactive oxygen species biosynthetic process |
| GO:0032502 | 0.00239 | 1.16196 | 512 | 565 | 6097 | developmental process |
| GO:0070848 | 0.00241 | 1.47146 | 51 | 71 | 604 | response to growth factor |
| GO:0034220 | 0.00241 | 1.39108 | 72 | 96 | 860 | ion transmembrane transport |
| GO:0052548 | 0.00247 | 1.65590 | 28 | 43 | 329 | regulation of endopeptidase activity |
| GO:1900542 | 0.00249 | 2.43789 | 7 | 16 | 88 | regulation of purine nucleotide metabolic process |
| GO:0034654 | 0.00251 | 1.20480 | 273 | 315 | 3250 | nucleobase-containing compound biosynthetic process |
| GO:0090130 | 0.00251 | 1.71417 | 24 | 38 | 282 | tissue migration |
| GO:0006228 | 0.00263 | 10.93782 | 1 | 4 | 8 | UTP biosynthetic process |
| GO:0071692 | 0.00263 | 10.93782 | 1 | 4 | 8 | protein localization to extracellular region |
| GO:1902253 | 0.00265 | 3.98221 | 3 | 8 | 30 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0006613 | 0.00266 | 5.47248 | 2 | 6 | 18 | cotranslational protein targeting to membrane |
| GO:0030150 | 0.00266 | 5.47248 | 2 | 6 | 18 | protein import into mitochondrial matrix |
| GO:0051444 | 0.00266 | 5.47248 | 2 | 6 | 18 | negative regulation of ubiquitin-protein transferase activity |
| GO:0032272 | 0.00271 | 2.60208 | 6 | 14 | 73 | negative regulation of protein polymerization |
| GO:0000375 | 0.00272 | 1.76423 | 21 | 34 | 246 | RNA splicing, via transesterification reactions |
| GO:0000377 | 0.00272 | 1.76423 | 21 | 34 | 246 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile |
| GO:0000398 | 0.00272 | 1.76423 | 21 | 34 | 246 | mRNA splicing, via spliceosome |
| GO:0048259 | 0.00273 | 2.27051 | 9 | 18 | 105 | regulation of receptor-mediated endocytosis |
| GO:0032461 | 0.00280 | 4.50801 | 2 | 7 | 24 | positive regulation of protein oligomerization |
| GO:1901798 | 0.00280 | 4.50801 | 2 | 7 | 24 | positive regulation of signal transduction by p53 class mediator |
| GO:0050920 | 0.00285 | 1.83238 | 18 | 30 | 210 | regulation of chemotaxis |
| GO:0042398 | 0.00290 | 3.52081 | 3 | 9 | 37 | cellular modified amino acid biosynthetic process |
| GO:0001822 | 0.00291 | 1.71073 | 23 | 37 | 275 | kidney development |
| GO:0014068 | 0.00297 | 2.68912 | 6 | 13 | 66 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:2000378 | 0.00297 | 2.68912 | 6 | 13 | 66 | negative regulation of reactive oxygen species metabolic process |
| GO:0009893 | 0.00300 | 1.19643 | 286 | 328 | 3406 | positive regulation of metabolic process |
| GO:0006122 | 0.00300 | 6.83837 | 1 | 5 | 13 | mitochondrial electron transport, ubiquinol to cytochrome c |
| GO:0006465 | 0.00300 | 6.83837 | 1 | 5 | 13 | signal peptide processing |
| GO:0009148 | 0.00300 | 6.83837 | 1 | 5 | 13 | pyrimidine nucleoside triphosphate biosynthetic process |
| GO:0009219 | 0.00300 | 6.83837 | 1 | 5 | 13 | pyrimidine deoxyribonucleotide metabolic process |
| GO:0046185 | 0.00300 | 6.83837 | 1 | 5 | 13 | aldehyde catabolic process |
| GO:0051093 | 0.00304 | 1.34359 | 88 | 113 | 1045 | negative regulation of developmental process |
| GO:0043254 | 0.00310 | 1.54233 | 37 | 54 | 440 | regulation of protein complex assembly |
| GO:0010639 | 0.00310 | 1.57874 | 33 | 49 | 391 | negative regulation of organelle organization |
| GO:0009914 | 0.00312 | 1.60348 | 30 | 46 | 362 | hormone transport |
| GO:0048878 | 0.00315 | 1.32553 | 97 | 123 | 1152 | chemical homeostasis |
| GO:0010942 | 0.00319 | 1.42982 | 56 | 77 | 672 | positive regulation of cell death |
| GO:0042278 | 0.00321 | 2.79850 | 5 | 12 | 59 | purine nucleoside metabolic process |
| GO:0043280 | 0.00325 | 2.17216 | 10 | 19 | 115 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:1901136 | 0.00325 | 2.17216 | 10 | 19 | 115 | carbohydrate derivative catabolic process |
| GO:0006935 | 0.00327 | 1.46738 | 48 | 67 | 571 | chemotaxis |
| GO:0042327 | 0.00329 | 1.34151 | 87 | 112 | 1037 | positive regulation of phosphorylation |
| GO:0070374 | 0.00332 | 1.73937 | 21 | 34 | 249 | positive regulation of ERK1 and ERK2 cascade |
| GO:0002090 | 0.00341 | 2.63920 | 6 | 13 | 67 | regulation of receptor internalization |
| GO:0072527 | 0.00341 | 2.94001 | 4 | 11 | 52 | pyrimidine-containing compound metabolic process |
| GO:1901570 | 0.00341 | 2.94001 | 4 | 11 | 52 | fatty acid derivative biosynthetic process |
| GO:0030031 | 0.00346 | 1.49731 | 42 | 60 | 502 | cell projection assembly |
| GO:0060255 | 0.00349 | 1.16106 | 452 | 501 | 5386 | regulation of macromolecule metabolic process |
| GO:0043403 | 0.00353 | 3.39924 | 3 | 9 | 38 | skeletal muscle tissue regeneration |
| GO:0006898 | 0.00353 | 1.80208 | 18 | 30 | 213 | receptor-mediated endocytosis |
| GO:0042273 | 0.00355 | 2.41917 | 7 | 15 | 83 | ribosomal large subunit biogenesis |
| GO:0042330 | 0.00355 | 1.46144 | 48 | 67 | 573 | taxis |
| GO:0007275 | 0.00359 | 1.16219 | 439 | 487 | 5227 | multicellular organism development |
| GO:0000303 | 0.00361 | 4.25736 | 2 | 7 | 25 | response to superoxide |
| GO:0006221 | 0.00361 | 4.25736 | 2 | 7 | 25 | pyrimidine nucleotide biosynthetic process |
| GO:1905952 | 0.00368 | 2.01296 | 12 | 22 | 142 | regulation of lipid localization |
| GO:0014911 | 0.00371 | 2.74007 | 5 | 12 | 60 | positive regulation of smooth muscle cell migration |
| GO:0048008 | 0.00371 | 2.74007 | 5 | 12 | 60 | platelet-derived growth factor receptor signaling pathway |
| GO:0051641 | 0.00376 | 1.21782 | 212 | 248 | 2523 | cellular localization |
| GO:0003015 | 0.00379 | 1.79220 | 18 | 30 | 214 | heart process |
| GO:0043112 | 0.00386 | 1.83151 | 16 | 28 | 196 | receptor metabolic process |
| GO:0010562 | 0.00387 | 1.32348 | 93 | 118 | 1106 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.00387 | 1.32348 | 93 | 118 | 1106 | positive regulation of phosphate metabolic process |
| GO:0048771 | 0.00388 | 1.85414 | 16 | 27 | 187 | tissue remodeling |
| GO:0006936 | 0.00395 | 1.67514 | 23 | 37 | 280 | muscle contraction |
| GO:0051271 | 0.00405 | 1.63647 | 26 | 40 | 309 | negative regulation of cellular component movement |
| GO:0051495 | 0.00406 | 1.78243 | 18 | 30 | 215 | positive regulation of cytoskeleton organization |
| GO:0044087 | 0.00407 | 1.35153 | 78 | 101 | 928 | regulation of cellular component biogenesis |
| GO:0010543 | 0.00409 | 3.65002 | 3 | 8 | 32 | regulation of platelet activation |
| GO:0008361 | 0.00411 | 1.80064 | 17 | 29 | 206 | regulation of cell size |
| GO:0060047 | 0.00411 | 1.80064 | 17 | 29 | 206 | heart contraction |
| GO:0045765 | 0.00418 | 1.64423 | 25 | 39 | 300 | regulation of angiogenesis |
| GO:0033173 | 0.00418 | 3.04310 | 4 | 10 | 46 | calcineurin-NFAT signaling cascade |
| GO:0017015 | 0.00428 | 2.22012 | 8 | 17 | 101 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0051897 | 0.00428 | 2.22012 | 8 | 17 | 101 | positive regulation of protein kinase B signaling |
| GO:0006662 | 0.00435 | 6.07826 | 1 | 5 | 14 | glycerol ether metabolic process |
| GO:0019370 | 0.00435 | 6.07826 | 1 | 5 | 14 | leukotriene biosynthetic process |
| GO:0043248 | 0.00435 | 6.07826 | 1 | 5 | 14 | proteasome assembly |
| GO:0090136 | 0.00435 | 6.07826 | 1 | 5 | 14 | epithelial cell-cell adhesion |
| GO:0050678 | 0.00437 | 1.58825 | 29 | 44 | 349 | regulation of epithelial cell proliferation |
| GO:0006241 | 0.00441 | 8.74985 | 1 | 4 | 9 | CTP biosynthetic process |
| GO:0017062 | 0.00441 | 8.74985 | 1 | 4 | 9 | respiratory chain complex III assembly |
| GO:0034551 | 0.00441 | 8.74985 | 1 | 4 | 9 | mitochondrial respiratory chain complex III assembly |
| GO:0035581 | 0.00441 | 8.74985 | 1 | 4 | 9 | sequestering of extracellular ligand from receptor |
| GO:0046036 | 0.00441 | 8.74985 | 1 | 4 | 9 | CTP metabolic process |
| GO:0046051 | 0.00441 | 8.74985 | 1 | 4 | 9 | UTP metabolic process |
| GO:0031399 | 0.00444 | 1.25383 | 146 | 176 | 1737 | regulation of protein modification process |
| GO:0072657 | 0.00448 | 1.47202 | 43 | 61 | 518 | protein localization to membrane |
| GO:0010035 | 0.00451 | 1.49253 | 40 | 57 | 478 | response to inorganic substance |
| GO:0000305 | 0.00458 | 4.03310 | 2 | 7 | 26 | response to oxygen radical |
| GO:0035929 | 0.00458 | 4.03310 | 2 | 7 | 26 | steroid hormone secretion |
| GO:0030199 | 0.00463 | 2.80300 | 5 | 11 | 54 | collagen fibril organization |
| GO:0042743 | 0.00463 | 2.80300 | 5 | 11 | 54 | hydrogen peroxide metabolic process |
| GO:0061061 | 0.00464 | 1.40550 | 57 | 77 | 682 | muscle structure development |
| GO:0051050 | 0.00471 | 1.32355 | 88 | 112 | 1049 | positive regulation of transport |
| GO:0120031 | 0.00471 | 1.48355 | 41 | 58 | 489 | plasma membrane bounded cell projection assembly |
| GO:0008535 | 0.00480 | 4.69026 | 2 | 6 | 20 | respiratory chain complex IV assembly |
| GO:0019430 | 0.00480 | 4.69026 | 2 | 6 | 20 | removal of superoxide radicals |
| GO:0060307 | 0.00480 | 4.69026 | 2 | 6 | 20 | regulation of ventricular cardiac muscle cell membrane repolarization |
| GO:0001816 | 0.00481 | 1.39375 | 60 | 80 | 714 | cytokine production |
| GO:0007265 | 0.00483 | 1.53760 | 34 | 49 | 400 | Ras protein signal transduction |
| GO:0090287 | 0.00500 | 1.67344 | 22 | 35 | 265 | regulation of cellular response to growth factor stimulus |
| GO:0009262 | 0.00501 | 3.50385 | 3 | 8 | 33 | deoxyribonucleotide metabolic process |
| GO:0030168 | 0.00507 | 2.39823 | 7 | 14 | 78 | platelet activation |
| GO:0002740 | 0.00518 | 16.39985 | 0 | 3 | 5 | negative regulation of cytokine secretion involved in immune response |
| GO:0007171 | 0.00518 | 16.39985 | 0 | 3 | 5 | activation of transmembrane receptor protein tyrosine kinase activity |
| GO:0061056 | 0.00518 | 16.39985 | 0 | 3 | 5 | sclerotome development |
| GO:0060048 | 0.00524 | 2.06414 | 10 | 19 | 120 | cardiac muscle contraction |
| GO:0019318 | 0.00530 | 1.74438 | 18 | 30 | 219 | hexose metabolic process |
| GO:0001933 | 0.00532 | 1.52874 | 34 | 49 | 402 | negative regulation of protein phosphorylation |
| GO:0046128 | 0.00536 | 2.73917 | 5 | 11 | 55 | purine ribonucleoside metabolic process |
| GO:0044093 | 0.00539 | 1.27374 | 118 | 145 | 1408 | positive regulation of molecular function |
| GO:0090150 | 0.00540 | 1.76051 | 18 | 29 | 210 | establishment of protein localization to membrane |
| GO:0045927 | 0.00552 | 1.61294 | 26 | 39 | 305 | positive regulation of growth |
| GO:0051346 | 0.00555 | 1.53204 | 33 | 48 | 393 | negative regulation of hydrolase activity |
| GO:0001649 | 0.00556 | 1.79753 | 16 | 27 | 192 | osteoblast differentiation |
| GO:0030308 | 0.00556 | 1.79753 | 16 | 27 | 192 | negative regulation of cell growth |
| GO:1902905 | 0.00556 | 1.79753 | 16 | 27 | 192 | positive regulation of supramolecular fiber organization |
| GO:0010952 | 0.00565 | 1.89858 | 13 | 23 | 156 | positive regulation of peptidase activity |
| GO:1903531 | 0.00566 | 1.73512 | 18 | 30 | 220 | negative regulation of secretion by cell |
| GO:0031623 | 0.00574 | 2.04381 | 10 | 19 | 121 | receptor internalization |
| GO:0009163 | 0.00575 | 3.83127 | 2 | 7 | 27 | nucleoside biosynthetic process |
| GO:0042455 | 0.00575 | 3.83127 | 2 | 7 | 27 | ribonucleoside biosynthetic process |
| GO:0061050 | 0.00575 | 3.83127 | 2 | 7 | 27 | regulation of cell growth involved in cardiac muscle cell development |
| GO:0017001 | 0.00576 | 2.88266 | 4 | 10 | 48 | antibiotic catabolic process |
| GO:0032459 | 0.00603 | 3.08013 | 3 | 9 | 41 | regulation of protein oligomerization |
| GO:0072001 | 0.00604 | 1.61375 | 25 | 38 | 297 | renal system development |
| GO:0051131 | 0.00608 | 5.47018 | 1 | 5 | 15 | chaperone-mediated protein complex assembly |
| GO:0061430 | 0.00608 | 5.47018 | 1 | 5 | 15 | bone trabecula morphogenesis |
| GO:1902165 | 0.00608 | 5.47018 | 1 | 5 | 15 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:0008360 | 0.00608 | 1.91656 | 12 | 22 | 148 | regulation of cell shape |
| GO:0010950 | 0.00608 | 1.91656 | 12 | 22 | 148 | positive regulation of endopeptidase activity |
| GO:0044248 | 0.00610 | 1.23150 | 161 | 191 | 1916 | cellular catabolic process |
| GO:0045637 | 0.00617 | 1.74111 | 18 | 29 | 212 | regulation of myeloid cell differentiation |
| GO:0048260 | 0.00618 | 2.67817 | 5 | 11 | 56 | positive regulation of receptor-mediated endocytosis |
| GO:0007155 | 0.00618 | 1.28211 | 107 | 132 | 1273 | cell adhesion |
| GO:0006691 | 0.00624 | 4.37737 | 2 | 6 | 21 | leukotriene metabolic process |
| GO:0032331 | 0.00624 | 4.37737 | 2 | 6 | 21 | negative regulation of chondrocyte differentiation |
| GO:0032760 | 0.00624 | 2.25295 | 7 | 15 | 88 | positive regulation of tumor necrosis factor production |
| GO:0016070 | 0.00627 | 1.17188 | 309 | 349 | 3688 | RNA metabolic process |
| GO:0090257 | 0.00628 | 1.70338 | 19 | 31 | 231 | regulation of muscle system process |
| GO:0022610 | 0.00638 | 1.27950 | 108 | 133 | 1285 | biological adhesion |
| GO:0050709 | 0.00653 | 1.93669 | 12 | 21 | 140 | negative regulation of protein secretion |
| GO:0071248 | 0.00659 | 1.90138 | 13 | 22 | 149 | cellular response to metal ion |
| GO:0010563 | 0.00670 | 1.43588 | 45 | 62 | 538 | negative regulation of phosphorus metabolic process |
| GO:0045936 | 0.00670 | 1.43588 | 45 | 62 | 538 | negative regulation of phosphate metabolic process |
| GO:0097720 | 0.00670 | 2.80862 | 4 | 10 | 49 | calcineurin-mediated signaling |
| GO:0001817 | 0.00680 | 1.39609 | 54 | 72 | 641 | regulation of cytokine production |
| GO:0002176 | 0.00687 | 7.29120 | 1 | 4 | 10 | male germ cell proliferation |
| GO:0002679 | 0.00687 | 7.29120 | 1 | 4 | 10 | respiratory burst involved in defense response |
| GO:0006000 | 0.00687 | 7.29120 | 1 | 4 | 10 | fructose metabolic process |
| GO:0006183 | 0.00687 | 7.29120 | 1 | 4 | 10 | GTP biosynthetic process |
| GO:0009209 | 0.00687 | 7.29120 | 1 | 4 | 10 | pyrimidine ribonucleoside triphosphate biosynthetic process |
| GO:0072321 | 0.00687 | 7.29120 | 1 | 4 | 10 | chaperone-mediated protein transport |
| GO:1900115 | 0.00687 | 7.29120 | 1 | 4 | 10 | extracellular regulation of signal transduction |
| GO:1900116 | 0.00687 | 7.29120 | 1 | 4 | 10 | extracellular negative regulation of signal transduction |
| GO:0051094 | 0.00689 | 1.25452 | 127 | 154 | 1516 | positive regulation of developmental process |
| GO:0031401 | 0.00693 | 1.28541 | 101 | 125 | 1202 | positive regulation of protein modification process |
| GO:0034446 | 0.00694 | 2.22240 | 7 | 15 | 89 | substrate adhesion-dependent cell spreading |
| GO:1903557 | 0.00694 | 2.22240 | 7 | 15 | 89 | positive regulation of tumor necrosis factor superfamily cytokine production |
| GO:0007264 | 0.00697 | 1.46707 | 39 | 55 | 468 | small GTPase mediated signal transduction |
| GO:0051336 | 0.00699 | 1.31831 | 81 | 103 | 967 | regulation of hydrolase activity |
| GO:1901657 | 0.00703 | 2.09490 | 9 | 17 | 106 | glycosyl compound metabolic process |
| GO:0001575 | 0.00704 | Inf | 0 | 2 | 2 | globoside metabolic process |
| GO:0005985 | 0.00704 | Inf | 0 | 2 | 2 | sucrose metabolic process |
| GO:0005986 | 0.00704 | Inf | 0 | 2 | 2 | sucrose biosynthetic process |
| GO:0006060 | 0.00704 | Inf | 0 | 2 | 2 | sorbitol metabolic process |
| GO:0010903 | 0.00704 | Inf | 0 | 2 | 2 | negative regulation of very-low-density lipoprotein particle remodeling |
| GO:0032972 | 0.00704 | Inf | 0 | 2 | 2 | regulation of muscle filament sliding speed |
| GO:0042262 | 0.00704 | Inf | 0 | 2 | 2 | DNA protection |
| GO:0060265 | 0.00704 | Inf | 0 | 2 | 2 | positive regulation of respiratory burst involved in inflammatory response |
| GO:0060854 | 0.00704 | Inf | 0 | 2 | 2 | branching involved in lymph vessel morphogenesis |
| GO:0097238 | 0.00704 | Inf | 0 | 2 | 2 | cellular response to methylglyoxal |
| GO:1901731 | 0.00704 | Inf | 0 | 2 | 2 | positive regulation of platelet aggregation |
| GO:1902988 | 0.00704 | Inf | 0 | 2 | 2 | neurofibrillary tangle assembly |
| GO:1902996 | 0.00704 | Inf | 0 | 2 | 2 | regulation of neurofibrillary tangle assembly |
| GO:1905938 | 0.00704 | Inf | 0 | 2 | 2 | positive regulation of germ cell proliferation |
| GO:2000256 | 0.00704 | Inf | 0 | 2 | 2 | positive regulation of male germ cell proliferation |
| GO:0001935 | 0.00708 | 1.92046 | 12 | 21 | 141 | endothelial cell proliferation |
| GO:0072528 | 0.00712 | 3.64865 | 2 | 7 | 28 | pyrimidine-containing compound biosynthetic process |
| GO:1902042 | 0.00712 | 3.64865 | 2 | 7 | 28 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0060389 | 0.00725 | 2.48099 | 5 | 12 | 65 | pathway-restricted SMAD protein phosphorylation |
| GO:0009060 | 0.00726 | 2.37461 | 6 | 13 | 73 | aerobic respiration |
| GO:0019319 | 0.00726 | 2.37461 | 6 | 13 | 73 | hexose biosynthetic process |
| GO:0080134 | 0.00727 | 1.27810 | 105 | 129 | 1247 | regulation of response to stress |
| GO:0006826 | 0.00732 | 3.24400 | 3 | 8 | 35 | iron ion transport |
| GO:0044092 | 0.00734 | 1.31209 | 83 | 105 | 990 | negative regulation of molecular function |
| GO:0034614 | 0.00767 | 1.90450 | 12 | 21 | 142 | cellular response to reactive oxygen species |
| GO:1900024 | 0.00776 | 2.73827 | 4 | 10 | 50 | regulation of substrate adhesion-dependent cell spreading |
| GO:2001057 | 0.00796 | 2.25673 | 7 | 14 | 82 | reactive nitrogen species metabolic process |
| GO:0032462 | 0.00799 | 4.10359 | 2 | 6 | 22 | regulation of protein homooligomerization |
| GO:0045606 | 0.00799 | 4.10359 | 2 | 6 | 22 | positive regulation of epidermal cell differentiation |
| GO:0071450 | 0.00799 | 4.10359 | 2 | 6 | 22 | cellular response to oxygen radical |
| GO:0071451 | 0.00799 | 4.10359 | 2 | 6 | 22 | cellular response to superoxide |
| GO:0099625 | 0.00799 | 4.10359 | 2 | 6 | 22 | ventricular cardiac muscle cell membrane repolarization |
| GO:0045595 | 0.00802 | 1.22439 | 157 | 186 | 1874 | regulation of cell differentiation |
| GO:0010604 | 0.00808 | 1.17681 | 264 | 300 | 3149 | positive regulation of macromolecule metabolic process |
| GO:0050848 | 0.00814 | 2.11370 | 8 | 16 | 99 | regulation of calcium-mediated signaling |
| GO:1902106 | 0.00814 | 2.11370 | 8 | 16 | 99 | negative regulation of leukocyte differentiation |
| GO:0006809 | 0.00814 | 2.33557 | 6 | 13 | 74 | nitric oxide biosynthetic process |
| GO:0045428 | 0.00821 | 2.43493 | 6 | 12 | 66 | regulation of nitric oxide biosynthetic process |
| GO:2001241 | 0.00824 | 4.97266 | 1 | 5 | 16 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0034341 | 0.00825 | 1.92483 | 11 | 20 | 134 | response to interferon-gamma |
| GO:0007179 | 0.00826 | 1.82935 | 14 | 23 | 161 | transforming growth factor beta receptor signaling pathway |
| GO:1904018 | 0.00835 | 1.73397 | 17 | 27 | 198 | positive regulation of vasculature development |
| GO:0031400 | 0.00837 | 1.41419 | 46 | 63 | 554 | negative regulation of protein modification process |
| GO:0030099 | 0.00839 | 1.49934 | 33 | 47 | 392 | myeloid cell differentiation |
| GO:0044782 | 0.00851 | 1.55447 | 27 | 40 | 323 | cilium organization |
| GO:0008284 | 0.00853 | 1.30727 | 82 | 103 | 974 | positive regulation of cell proliferation |
| GO:0045766 | 0.00866 | 1.77076 | 15 | 25 | 180 | positive regulation of angiogenesis |
| GO:0046879 | 0.00869 | 1.52595 | 30 | 43 | 353 | hormone secretion |
| GO:0001958 | 0.00871 | 3.48264 | 2 | 7 | 29 | endochondral ossification |
| GO:0002092 | 0.00871 | 3.48264 | 2 | 7 | 29 | positive regulation of receptor internalization |
| GO:0034110 | 0.00871 | 3.48264 | 2 | 7 | 29 | regulation of homotypic cell-cell adhesion |
| GO:0036075 | 0.00871 | 3.48264 | 2 | 7 | 29 | replacement ossification |
| GO:0061037 | 0.00871 | 3.48264 | 2 | 7 | 29 | negative regulation of cartilage development |
| GO:0046470 | 0.00873 | 3.12800 | 3 | 8 | 36 | phosphatidylcholine metabolic process |
| GO:1904062 | 0.00894 | 1.54893 | 27 | 40 | 324 | regulation of cation transmembrane transport |
| GO:0002683 | 0.00903 | 1.45533 | 38 | 53 | 454 | negative regulation of immune system process |
| GO:0032507 | 0.00911 | 2.29779 | 6 | 13 | 75 | maintenance of protein location in cell |
| GO:1903578 | 0.00911 | 2.29779 | 6 | 13 | 75 | regulation of ATP metabolic process |
| GO:0009119 | 0.00925 | 2.39054 | 6 | 12 | 67 | ribonucleoside metabolic process |
| GO:0032370 | 0.00925 | 2.39054 | 6 | 12 | 67 | positive regulation of lipid transport |
| GO:0019722 | 0.00926 | 1.69892 | 18 | 28 | 209 | calcium-mediated signaling |
| GO:0048144 | 0.00927 | 2.02630 | 9 | 17 | 109 | fibroblast proliferation |
| GO:0051248 | 0.00930 | 1.29129 | 88 | 110 | 1052 | negative regulation of protein metabolic process |
| GO:0008016 | 0.00943 | 1.77999 | 14 | 24 | 172 | regulation of heart contraction |
| GO:0042326 | 0.00946 | 1.45673 | 37 | 52 | 445 | negative regulation of phosphorylation |
| GO:0043269 | 0.00958 | 1.35698 | 59 | 77 | 703 | regulation of ion transport |
| GO:1903707 | 0.00964 | 1.82892 | 13 | 22 | 154 | negative regulation of hemopoiesis |
| GO:0002536 | 0.00972 | 10.93272 | 1 | 3 | 6 | respiratory burst involved in inflammatory response |
| GO:0006167 | 0.00972 | 10.93272 | 1 | 3 | 6 | AMP biosynthetic process |
| GO:0010273 | 0.00972 | 10.93272 | 1 | 3 | 6 | detoxification of copper ion |
| GO:0015846 | 0.00972 | 10.93272 | 1 | 3 | 6 | polyamine transport |
| GO:0046826 | 0.00972 | 10.93272 | 1 | 3 | 6 | negative regulation of protein export from nucleus |
| GO:0051541 | 0.00972 | 10.93272 | 1 | 3 | 6 | elastin metabolic process |
| GO:1902047 | 0.00972 | 10.93272 | 1 | 3 | 6 | polyamine transmembrane transport |
| GO:1990169 | 0.00972 | 10.93272 | 1 | 3 | 6 | stress response to copper ion |
| GO:2000554 | 0.00972 | 10.93272 | 1 | 3 | 6 | regulation of T-helper 1 cell cytokine production |
| GO:2000556 | 0.00972 | 10.93272 | 1 | 3 | 6 | positive regulation of T-helper 1 cell cytokine production |
| GO:0002063 | 0.00973 | 2.81572 | 4 | 9 | 44 | chondrocyte development |
| GO:0009116 | 0.00983 | 2.19205 | 7 | 14 | 84 | nucleoside metabolic process |
| GO:0040013 | 0.00986 | 1.53795 | 27 | 40 | 326 | negative regulation of locomotion |
| GO:0071214 | 0.00997 | 1.57649 | 24 | 36 | 287 | cellular response to abiotic stimulus |
| GO:0104004 | 0.00997 | 1.57649 | 24 | 36 | 287 | cellular response to environmental stimulus |
| GO:1903706 | 0.01003 | 1.48187 | 33 | 47 | 396 | regulation of hemopoiesis |
| GO:0099149 | 0.01005 | 3.86202 | 2 | 6 | 23 | regulation of postsynaptic neurotransmitter receptor internalization |
| GO:0009208 | 0.01009 | 6.24930 | 1 | 4 | 11 | pyrimidine ribonucleoside triphosphate metabolic process |
| GO:0010872 | 0.01009 | 6.24930 | 1 | 4 | 11 | regulation of cholesterol esterification |
| GO:0032490 | 0.01009 | 6.24930 | 1 | 4 | 11 | detection of molecule of bacterial origin |
| GO:0035999 | 0.01009 | 6.24930 | 1 | 4 | 11 | tetrahydrofolate interconversion |
| GO:0036093 | 0.01009 | 6.24930 | 1 | 4 | 11 | germ cell proliferation |
| GO:0046386 | 0.01009 | 6.24930 | 1 | 4 | 11 | deoxyribose phosphate catabolic process |
| GO:0051901 | 0.01009 | 6.24930 | 1 | 4 | 11 | positive regulation of mitochondrial depolarization |
| GO:1902231 | 0.01009 | 6.24930 | 1 | 4 | 11 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0015850 | 0.01014 | 1.63725 | 20 | 31 | 239 | organic hydroxy compound transport |
| GO:0034644 | 0.01017 | 2.26121 | 6 | 13 | 76 | cellular response to UV |
| GO:0001954 | 0.01027 | 2.60763 | 4 | 10 | 52 | positive regulation of cell-matrix adhesion |
| GO:0051496 | 0.01027 | 2.60763 | 4 | 10 | 52 | positive regulation of stress fiber assembly |
| GO:0003009 | 0.01034 | 3.01999 | 3 | 8 | 37 | skeletal muscle contraction |
| GO:0045684 | 0.01034 | 3.01999 | 3 | 8 | 37 | positive regulation of epidermis development |
| GO:1902229 | 0.01034 | 3.01999 | 3 | 8 | 37 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0005996 | 0.01038 | 1.62012 | 21 | 32 | 249 | monosaccharide metabolic process |
| GO:0006081 | 0.01040 | 2.34774 | 6 | 12 | 68 | cellular aldehyde metabolic process |
| GO:0034470 | 0.01041 | 1.52321 | 28 | 41 | 337 | ncRNA processing |
| GO:0002825 | 0.01056 | 3.33107 | 3 | 7 | 30 | regulation of T-helper 1 type immune response |
| GO:0032232 | 0.01056 | 3.33107 | 3 | 7 | 30 | negative regulation of actin filament bundle assembly |
| GO:0042744 | 0.01056 | 3.33107 | 3 | 7 | 30 | hydrogen peroxide catabolic process |
| GO:0045652 | 0.01056 | 3.33107 | 3 | 7 | 30 | regulation of megakaryocyte differentiation |
| GO:0061036 | 0.01056 | 3.33107 | 3 | 7 | 30 | positive regulation of cartilage development |
| GO:0120032 | 0.01060 | 1.73689 | 15 | 25 | 183 | regulation of plasma membrane bounded cell projection assembly |
| GO:0006516 | 0.01088 | 4.55805 | 1 | 5 | 17 | glycoprotein catabolic process |
| GO:0006614 | 0.01088 | 4.55805 | 1 | 5 | 17 | SRP-dependent cotranslational protein targeting to membrane |
| GO:0045019 | 0.01088 | 4.55805 | 1 | 5 | 17 | negative regulation of nitric oxide biosynthetic process |
| GO:1902547 | 0.01088 | 4.55805 | 1 | 5 | 17 | regulation of cellular response to vascular endothelial growth factor stimulus |
| GO:1904406 | 0.01088 | 4.55805 | 1 | 5 | 17 | negative regulation of nitric oxide metabolic process |
| GO:1904666 | 0.01088 | 4.55805 | 1 | 5 | 17 | regulation of ubiquitin protein ligase activity |
| GO:0051224 | 0.01105 | 1.70918 | 16 | 26 | 193 | negative regulation of protein transport |
| GO:0001952 | 0.01105 | 1.98300 | 9 | 17 | 111 | regulation of cell-matrix adhesion |
| GO:0009132 | 0.01105 | 1.98300 | 9 | 17 | 111 | nucleoside diphosphate metabolic process |
| GO:0048705 | 0.01117 | 1.59722 | 22 | 33 | 260 | skeletal system morphogenesis |
| GO:0006397 | 0.01122 | 1.44671 | 37 | 51 | 439 | mRNA processing |
| GO:0010821 | 0.01130 | 1.89445 | 11 | 19 | 129 | regulation of mitochondrion organization |
| GO:0046209 | 0.01132 | 2.22578 | 6 | 13 | 77 | nitric oxide metabolic process |
| GO:0050663 | 0.01147 | 1.65011 | 19 | 29 | 222 | cytokine secretion |
| GO:0051260 | 0.01148 | 1.49655 | 30 | 43 | 359 | protein homooligomerization |
| GO:0051046 | 0.01152 | 1.30810 | 74 | 93 | 878 | regulation of secretion |
| GO:0048522 | 0.01165 | 1.13484 | 449 | 490 | 5349 | positive regulation of cellular process |
| GO:0050732 | 0.01173 | 2.54687 | 4 | 10 | 53 | negative regulation of peptidyl-tyrosine phosphorylation |
| GO:0045860 | 0.01176 | 1.44799 | 36 | 50 | 430 | positive regulation of protein kinase activity |
| GO:0051924 | 0.01179 | 1.59014 | 22 | 33 | 261 | regulation of calcium ion transport |
| GO:1902305 | 0.01181 | 2.40979 | 5 | 11 | 61 | regulation of sodium ion transmembrane transport |
| GO:0008630 | 0.01204 | 1.96203 | 9 | 17 | 112 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0060491 | 0.01207 | 1.71502 | 16 | 25 | 185 | regulation of cell projection assembly |
| GO:0044089 | 0.01221 | 1.40032 | 44 | 59 | 523 | positive regulation of cellular component biogenesis |
| GO:0061041 | 0.01223 | 1.87730 | 11 | 19 | 130 | regulation of wound healing |
| GO:0046688 | 0.01247 | 3.64729 | 2 | 6 | 24 | response to copper ion |
| GO:0070584 | 0.01247 | 3.64729 | 2 | 6 | 24 | mitochondrion morphogenesis |
| GO:0099623 | 0.01247 | 3.64729 | 2 | 6 | 24 | regulation of cardiac muscle cell membrane repolarization |
| GO:0043410 | 0.01253 | 1.39408 | 45 | 60 | 534 | positive regulation of MAPK cascade |
| GO:0050707 | 0.01254 | 1.68879 | 16 | 26 | 195 | regulation of cytokine secretion |
| GO:0120162 | 0.01254 | 2.05514 | 8 | 15 | 95 | positive regulation of cold-induced thermogenesis |
| GO:0000387 | 0.01268 | 3.19212 | 3 | 7 | 31 | spliceosomal snRNP assembly |
| GO:0000462 | 0.01268 | 3.19212 | 3 | 7 | 31 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO:1901659 | 0.01268 | 3.19212 | 3 | 7 | 31 | glycosyl compound biosynthetic process |
| GO:0045859 | 0.01279 | 1.35396 | 54 | 71 | 649 | regulation of protein kinase activity |
| GO:2001234 | 0.01288 | 1.63303 | 19 | 29 | 224 | negative regulation of apoptotic signaling pathway |
| GO:0048738 | 0.01292 | 1.59050 | 21 | 32 | 253 | cardiac muscle tissue development |
| GO:0051289 | 0.01326 | 2.10166 | 7 | 14 | 87 | protein homotetramerization |
| GO:0060393 | 0.01330 | 2.36243 | 5 | 11 | 62 | regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0048016 | 0.01334 | 2.48887 | 5 | 10 | 54 | inositol phosphate-mediated signaling |
| GO:0051222 | 0.01337 | 1.44145 | 35 | 49 | 423 | positive regulation of protein transport |
| GO:0031326 | 0.01343 | 1.15724 | 284 | 318 | 3386 | regulation of cellular biosynthetic process |
| GO:0032880 | 0.01355 | 1.28118 | 83 | 103 | 991 | regulation of protein localization |
| GO:0015672 | 0.01360 | 1.42350 | 38 | 52 | 454 | monovalent inorganic cation transport |
| GO:0046849 | 0.01374 | 2.02967 | 8 | 15 | 96 | bone remodeling |
| GO:0034404 | 0.01375 | 1.76176 | 13 | 22 | 159 | nucleobase-containing small molecule biosynthetic process |
| GO:0010038 | 0.01382 | 1.56927 | 22 | 33 | 264 | response to metal ion |
| GO:0003013 | 0.01388 | 1.41174 | 40 | 54 | 475 | circulatory system process |
| GO:0038034 | 0.01393 | 2.15812 | 7 | 13 | 79 | signal transduction in absence of ligand |
| GO:0046364 | 0.01393 | 2.15812 | 7 | 13 | 79 | monosaccharide biosynthetic process |
| GO:0097192 | 0.01393 | 2.15812 | 7 | 13 | 79 | extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0071902 | 0.01397 | 1.55634 | 23 | 34 | 274 | positive regulation of protein serine/threonine kinase activity |
| GO:0002792 | 0.01397 | 1.78572 | 13 | 21 | 150 | negative regulation of peptide secretion |
| GO:0018904 | 0.01404 | 4.20724 | 2 | 5 | 18 | ether metabolic process |
| GO:0070886 | 0.01404 | 4.20724 | 2 | 5 | 18 | positive regulation of calcineurin-NFAT signaling cascade |
| GO:0106058 | 0.01404 | 4.20724 | 2 | 5 | 18 | positive regulation of calcineurin-mediated signaling |
| GO:0046474 | 0.01406 | 1.97065 | 9 | 16 | 105 | glycerophospholipid biosynthetic process |
| GO:0009264 | 0.01414 | 5.46788 | 1 | 4 | 12 | deoxyribonucleotide catabolic process |
| GO:0034350 | 0.01414 | 5.46788 | 1 | 4 | 12 | regulation of glial cell apoptotic process |
| GO:0042989 | 0.01414 | 5.46788 | 1 | 4 | 12 | sequestering of actin monomers |
| GO:0072110 | 0.01414 | 5.46788 | 1 | 4 | 12 | glomerular mesangial cell proliferation |
| GO:0097428 | 0.01414 | 5.46788 | 1 | 4 | 12 | protein maturation by iron-sulfur cluster transfer |
| GO:1904950 | 0.01417 | 1.66888 | 17 | 26 | 197 | negative regulation of establishment of protein localization |
| GO:0046883 | 0.01420 | 1.53321 | 25 | 36 | 294 | regulation of hormone secretion |
| GO:2001056 | 0.01425 | 1.84390 | 11 | 19 | 132 | positive regulation of cysteine-type endopeptidase activity |
| GO:0051092 | 0.01429 | 1.87968 | 10 | 18 | 123 | positive regulation of NF-kappaB transcription factor activity |
| GO:0031397 | 0.01451 | 2.22805 | 6 | 12 | 71 | negative regulation of protein ubiquitination |
| GO:0008015 | 0.01456 | 1.41223 | 39 | 53 | 466 | blood circulation |
| GO:0002685 | 0.01459 | 1.68321 | 16 | 25 | 188 | regulation of leukocyte migration |
| GO:2000146 | 0.01470 | 1.54981 | 23 | 34 | 275 | negative regulation of cell motility |
| GO:0120036 | 0.01490 | 1.22564 | 125 | 148 | 1485 | plasma membrane bounded cell projection organization |
| GO:0042088 | 0.01493 | 2.59306 | 4 | 9 | 47 | T-helper 1 type immune response |
| GO:1904036 | 0.01493 | 2.59306 | 4 | 9 | 47 | negative regulation of epithelial cell apoptotic process |
| GO:2000725 | 0.01493 | 2.59306 | 4 | 9 | 47 | regulation of cardiac muscle cell differentiation |
| GO:0032233 | 0.01493 | 2.31689 | 5 | 11 | 63 | positive regulation of actin filament bundle assembly |
| GO:0007031 | 0.01508 | 3.06429 | 3 | 7 | 32 | peroxisome organization |
| GO:0002335 | 0.01527 | 3.45517 | 2 | 6 | 25 | mature B cell differentiation |
| GO:0006213 | 0.01527 | 3.45517 | 2 | 6 | 25 | pyrimidine nucleoside metabolic process |
| GO:0010742 | 0.01527 | 3.45517 | 2 | 6 | 25 | macrophage derived foam cell differentiation |
| GO:0072331 | 0.01536 | 1.82764 | 11 | 19 | 133 | signal transduction by p53 class mediator |
| GO:0048518 | 0.01538 | 1.12309 | 506 | 547 | 6033 | positive regulation of biological process |
| GO:0043154 | 0.01539 | 2.12581 | 7 | 13 | 80 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0030030 | 0.01553 | 1.22056 | 128 | 152 | 1531 | cell projection organization |
| GO:0022604 | 0.01557 | 1.38810 | 43 | 57 | 509 | regulation of cell morphogenesis |
| GO:0002576 | 0.01596 | 8.19915 | 1 | 3 | 7 | platelet degranulation |
| GO:0019062 | 0.01596 | 8.19915 | 1 | 3 | 7 | virion attachment to host cell |
| GO:0032493 | 0.01596 | 8.19915 | 1 | 3 | 7 | response to bacterial lipoprotein |
| GO:0060373 | 0.01596 | 8.19915 | 1 | 3 | 7 | regulation of ventricular cardiac muscle cell membrane depolarization |
| GO:1905936 | 0.01596 | 8.19915 | 1 | 3 | 7 | regulation of germ cell proliferation |
| GO:2000254 | 0.01596 | 8.19915 | 1 | 3 | 7 | regulation of male germ cell proliferation |
| GO:0051896 | 0.01605 | 1.75829 | 13 | 21 | 152 | regulation of protein kinase B signaling |
| GO:0006259 | 0.01607 | 1.28765 | 75 | 93 | 890 | DNA metabolic process |
| GO:0034762 | 0.01607 | 1.37333 | 45 | 60 | 541 | regulation of transmembrane transport |
| GO:0016485 | 0.01612 | 1.59990 | 19 | 29 | 228 | protein processing |
| GO:0034105 | 0.01648 | 2.73648 | 3 | 8 | 40 | positive regulation of tissue remodeling |
| GO:0048145 | 0.01664 | 1.92716 | 9 | 16 | 107 | regulation of fibroblast proliferation |
| GO:0060349 | 0.01672 | 1.88240 | 10 | 17 | 116 | bone morphogenesis |
| GO:0070925 | 0.01677 | 1.30658 | 65 | 82 | 774 | organelle assembly |
| GO:2001236 | 0.01681 | 1.72376 | 14 | 22 | 162 | regulation of extrinsic apoptotic signaling pathway |
| GO:0014706 | 0.01682 | 1.41388 | 37 | 50 | 439 | striated muscle tissue development |
| GO:0002275 | 0.01697 | 2.09445 | 7 | 13 | 81 | myeloid cell activation involved in immune response |
| GO:2001239 | 0.01704 | 2.52645 | 4 | 9 | 48 | regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0050727 | 0.01725 | 1.49122 | 27 | 38 | 318 | regulation of inflammatory response |
| GO:1902532 | 0.01733 | 1.37875 | 43 | 57 | 512 | negative regulation of intracellular signal transduction |
| GO:0014066 | 0.01755 | 2.01842 | 8 | 14 | 90 | regulation of phosphatidylinositol 3-kinase signaling |
| GO:0070167 | 0.01755 | 2.01842 | 8 | 14 | 90 | regulation of biomineral tissue development |
| GO:0033630 | 0.01776 | 3.90654 | 2 | 5 | 19 | positive regulation of cell adhesion mediated by integrin |
| GO:0050884 | 0.01776 | 3.90654 | 2 | 5 | 19 | neuromuscular process controlling posture |
| GO:0090201 | 0.01776 | 3.90654 | 2 | 5 | 19 | negative regulation of release of cytochrome c from mitochondria |
| GO:0090322 | 0.01779 | 2.94630 | 3 | 7 | 33 | regulation of superoxide metabolic process |
| GO:1903034 | 0.01794 | 1.71146 | 14 | 22 | 163 | regulation of response to wounding |
| GO:0032102 | 0.01805 | 1.48585 | 27 | 38 | 319 | negative regulation of response to external stimulus |
| GO:0001776 | 0.01806 | 1.90612 | 9 | 16 | 108 | leukocyte homeostasis |
| GO:0031344 | 0.01844 | 1.30450 | 63 | 80 | 756 | regulation of cell projection organization |
| GO:0000470 | 0.01847 | 3.28225 | 2 | 6 | 26 | maturation of LSU-rRNA |
| GO:0002082 | 0.01847 | 3.28225 | 2 | 6 | 26 | regulation of oxidative phosphorylation |
| GO:0010954 | 0.01847 | 3.28225 | 2 | 6 | 26 | positive regulation of protein processing |
| GO:0090077 | 0.01847 | 3.28225 | 2 | 6 | 26 | foam cell differentiation |
| GO:0019058 | 0.01858 | 1.64258 | 16 | 25 | 192 | viral life cycle |
| GO:0010632 | 0.01868 | 1.59238 | 19 | 28 | 221 | regulation of epithelial cell migration |
| GO:0010817 | 0.01871 | 1.36423 | 45 | 59 | 535 | regulation of hormone levels |
| GO:0042133 | 0.01876 | 1.75453 | 12 | 20 | 145 | neurotransmitter metabolic process |
| GO:0001655 | 0.01878 | 1.46520 | 29 | 40 | 340 | urogenital system development |
| GO:0031145 | 0.01909 | 4.86011 | 1 | 4 | 13 | anaphase-promoting complex-dependent catabolic process |
| GO:0032926 | 0.01909 | 4.86011 | 1 | 4 | 13 | negative regulation of activin receptor signaling pathway |
| GO:0038065 | 0.01909 | 4.86011 | 1 | 4 | 13 | collagen-activated signaling pathway |
| GO:0042891 | 0.01909 | 4.86011 | 1 | 4 | 13 | antibiotic transport |
| GO:0072216 | 0.01909 | 4.86011 | 1 | 4 | 13 | positive regulation of metanephros development |
| GO:0090197 | 0.01909 | 4.86011 | 1 | 4 | 13 | positive regulation of chemokine secretion |
| GO:0099116 | 0.01909 | 4.86011 | 1 | 4 | 13 | tRNA 5'-end processing |
| GO:1901070 | 0.01909 | 4.86011 | 1 | 4 | 13 | guanosine-containing compound biosynthetic process |
| GO:1904181 | 0.01909 | 4.86011 | 1 | 4 | 13 | positive regulation of membrane depolarization |
| GO:2000833 | 0.01909 | 4.86011 | 1 | 4 | 13 | positive regulation of steroid hormone secretion |
| GO:1903510 | 0.01917 | 2.32968 | 5 | 10 | 57 | mucopolysaccharide metabolic process |
| GO:0048864 | 0.01919 | 1.99211 | 8 | 14 | 91 | stem cell development |
| GO:0070887 | 0.01921 | 1.15617 | 246 | 276 | 2933 | cellular response to chemical stimulus |
| GO:0120035 | 0.01934 | 1.30343 | 63 | 79 | 747 | regulation of plasma membrane bounded cell projection organization |
| GO:0001936 | 0.01936 | 1.81036 | 11 | 18 | 127 | regulation of endothelial cell proliferation |
| GO:0032941 | 0.01937 | 2.46318 | 4 | 9 | 49 | secretion by tissue |
| GO:0050850 | 0.01937 | 2.46318 | 4 | 9 | 49 | positive regulation of calcium-mediated signaling |
| GO:1902041 | 0.01937 | 2.46318 | 4 | 9 | 49 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0019725 | 0.01947 | 1.27394 | 76 | 94 | 908 | cellular homeostasis |
| GO:0009719 | 0.01962 | 1.22092 | 116 | 138 | 1388 | response to endogenous stimulus |
| GO:0051881 | 0.01974 | 2.11994 | 6 | 12 | 74 | regulation of mitochondrial membrane potential |
| GO:0006886 | 0.01974 | 1.27644 | 74 | 92 | 887 | intracellular protein transport |
| GO:0002337 | 0.01993 | 21.85626 | 0 | 2 | 3 | B-1a B cell differentiation |
| GO:0002540 | 0.01993 | 21.85626 | 0 | 2 | 3 | leukotriene production involved in inflammatory response |
| GO:0002554 | 0.01993 | 21.85626 | 0 | 2 | 3 | serotonin secretion by platelet |
| GO:0003347 | 0.01993 | 21.85626 | 0 | 2 | 3 | epicardial cell to mesenchymal cell transition |
| GO:0006059 | 0.01993 | 21.85626 | 0 | 2 | 3 | hexitol metabolic process |
| GO:0006296 | 0.01993 | 21.85626 | 0 | 2 | 3 | nucleotide-excision repair, DNA incision, 5'-to lesion |
| GO:0007056 | 0.01993 | 21.85626 | 0 | 2 | 3 | spindle assembly involved in female meiosis |
| GO:0010643 | 0.01993 | 21.85626 | 0 | 2 | 3 | cell communication by chemical coupling |
| GO:0010901 | 0.01993 | 21.85626 | 0 | 2 | 3 | regulation of very-low-density lipoprotein particle remodeling |
| GO:0018002 | 0.01993 | 21.85626 | 0 | 2 | 3 | N-terminal peptidyl-glutamic acid acetylation |
| GO:0019371 | 0.01993 | 21.85626 | 0 | 2 | 3 | cyclooxygenase pathway |
| GO:0031120 | 0.01993 | 21.85626 | 0 | 2 | 3 | snRNA pseudouridine synthesis |
| GO:0031204 | 0.01993 | 21.85626 | 0 | 2 | 3 | posttranslational protein targeting to membrane, translocation |
| GO:0032474 | 0.01993 | 21.85626 | 0 | 2 | 3 | otolith morphogenesis |
| GO:0034499 | 0.01993 | 21.85626 | 0 | 2 | 3 | late endosome to Golgi transport |
| GO:0035793 | 0.01993 | 21.85626 | 0 | 2 | 3 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway |
| GO:0036118 | 0.01993 | 21.85626 | 0 | 2 | 3 | hyaluranon cable assembly |
| GO:0036215 | 0.01993 | 21.85626 | 0 | 2 | 3 | response to stem cell factor |
| GO:0036216 | 0.01993 | 21.85626 | 0 | 2 | 3 | cellular response to stem cell factor stimulus |
| GO:0038109 | 0.01993 | 21.85626 | 0 | 2 | 3 | Kit signaling pathway |
| GO:0044208 | 0.01993 | 21.85626 | 0 | 2 | 3 | 'de novo' AMP biosynthetic process |
| GO:0044691 | 0.01993 | 21.85626 | 0 | 2 | 3 | tooth eruption |
| GO:0045218 | 0.01993 | 21.85626 | 0 | 2 | 3 | zonula adherens maintenance |
| GO:0048499 | 0.01993 | 21.85626 | 0 | 2 | 3 | synaptic vesicle membrane organization |
| GO:0051595 | 0.01993 | 21.85626 | 0 | 2 | 3 | response to methylglyoxal |
| GO:0060309 | 0.01993 | 21.85626 | 0 | 2 | 3 | elastin catabolic process |
| GO:0061146 | 0.01993 | 21.85626 | 0 | 2 | 3 | Peyer's patch morphogenesis |
| GO:0061182 | 0.01993 | 21.85626 | 0 | 2 | 3 | negative regulation of chondrocyte development |
| GO:0061623 | 0.01993 | 21.85626 | 0 | 2 | 3 | glycolytic process from galactose |
| GO:0071725 | 0.01993 | 21.85626 | 0 | 2 | 3 | response to triacyl bacterial lipopeptide |
| GO:0071727 | 0.01993 | 21.85626 | 0 | 2 | 3 | cellular response to triacyl bacterial lipopeptide |
| GO:0072061 | 0.01993 | 21.85626 | 0 | 2 | 3 | inner medullary collecting duct development |
| GO:0086047 | 0.01993 | 21.85626 | 0 | 2 | 3 | membrane depolarization during Purkinje myocyte cell action potential |
| GO:0098883 | 0.01993 | 21.85626 | 0 | 2 | 3 | synapse pruning |
| GO:0099152 | 0.01993 | 21.85626 | 0 | 2 | 3 | regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane |
| GO:0110095 | 0.01993 | 21.85626 | 0 | 2 | 3 | cellular detoxification of aldehyde |
| GO:1900104 | 0.01993 | 21.85626 | 0 | 2 | 3 | regulation of hyaluranon cable assembly |
| GO:1900106 | 0.01993 | 21.85626 | 0 | 2 | 3 | positive regulation of hyaluranon cable assembly |
| GO:1900238 | 0.01993 | 21.85626 | 0 | 2 | 3 | regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway |
| GO:1901656 | 0.01993 | 21.85626 | 0 | 2 | 3 | glycoside transport |
| GO:1902167 | 0.01993 | 21.85626 | 0 | 2 | 3 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:1902174 | 0.01993 | 21.85626 | 0 | 2 | 3 | positive regulation of keratinocyte apoptotic process |
| GO:1902445 | 0.01993 | 21.85626 | 0 | 2 | 3 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death |
| GO:1902956 | 0.01993 | 21.85626 | 0 | 2 | 3 | regulation of mitochondrial electron transport, NADH to ubiquinone |
| GO:1904109 | 0.01993 | 21.85626 | 0 | 2 | 3 | positive regulation of cholesterol import |
| GO:1904578 | 0.01993 | 21.85626 | 0 | 2 | 3 | response to thapsigargin |
| GO:1904579 | 0.01993 | 21.85626 | 0 | 2 | 3 | cellular response to thapsigargin |
| GO:1905907 | 0.01993 | 21.85626 | 0 | 2 | 3 | negative regulation of amyloid fibril formation |
| GO:2000297 | 0.01993 | 21.85626 | 0 | 2 | 3 | negative regulation of synapse maturation |
| GO:2000591 | 0.01993 | 21.85626 | 0 | 2 | 3 | positive regulation of metanephric mesenchymal cell migration |
| GO:2000911 | 0.01993 | 21.85626 | 0 | 2 | 3 | positive regulation of sterol import |
| GO:0007507 | 0.02039 | 1.33340 | 51 | 66 | 611 | heart development |
| GO:0032642 | 0.02049 | 2.03442 | 7 | 13 | 83 | regulation of chemokine production |
| GO:0051259 | 0.02074 | 1.33511 | 50 | 65 | 601 | protein complex oligomerization |
| GO:0038084 | 0.02082 | 2.83704 | 3 | 7 | 34 | vascular endothelial growth factor signaling pathway |
| GO:1901068 | 0.02082 | 2.83704 | 3 | 7 | 34 | guanosine-containing compound metabolic process |
| GO:0043542 | 0.02087 | 1.62299 | 16 | 25 | 194 | endothelial cell migration |
| GO:1901222 | 0.02094 | 1.96648 | 8 | 14 | 92 | regulation of NIK/NF-kappaB signaling |
| GO:0051651 | 0.02115 | 1.91121 | 8 | 15 | 101 | maintenance of location in cell |
| GO:0050730 | 0.02142 | 1.53298 | 21 | 31 | 253 | regulation of peptidyl-tyrosine phosphorylation |
| GO:0062012 | 0.02146 | 1.45738 | 28 | 39 | 333 | regulation of small molecule metabolic process |
| GO:0032835 | 0.02148 | 2.28104 | 5 | 10 | 58 | glomerulus development |
| GO:0001819 | 0.02159 | 1.39986 | 36 | 48 | 425 | positive regulation of cytokine production |
| GO:0002793 | 0.02161 | 1.47254 | 26 | 37 | 313 | positive regulation of peptide secretion |
| GO:0002718 | 0.02177 | 2.08620 | 6 | 12 | 75 | regulation of cytokine production involved in immune response |
| GO:0030490 | 0.02180 | 2.57527 | 4 | 8 | 42 | maturation of SSU-rRNA |
| GO:0050918 | 0.02180 | 2.57527 | 4 | 8 | 42 | positive chemotaxis |
| GO:0002687 | 0.02195 | 1.75043 | 12 | 19 | 138 | positive regulation of leukocyte migration |
| GO:0006816 | 0.02206 | 1.40853 | 34 | 46 | 405 | calcium ion transport |
| GO:0046131 | 0.02208 | 3.64593 | 2 | 5 | 20 | pyrimidine ribonucleoside metabolic process |
| GO:0046653 | 0.02208 | 3.64593 | 2 | 5 | 20 | tetrahydrofolate metabolic process |
| GO:0090330 | 0.02208 | 3.64593 | 2 | 5 | 20 | regulation of platelet aggregation |
| GO:2000010 | 0.02208 | 3.64593 | 2 | 5 | 20 | positive regulation of protein localization to cell surface |
| GO:0055001 | 0.02210 | 1.61337 | 16 | 25 | 195 | muscle cell development |
| GO:0045780 | 0.02211 | 3.12581 | 2 | 6 | 27 | positive regulation of bone resorption |
| GO:0046852 | 0.02211 | 3.12581 | 2 | 6 | 27 | positive regulation of bone remodeling |
| GO:0090200 | 0.02211 | 3.12581 | 2 | 6 | 27 | positive regulation of release of cytochrome c from mitochondria |
| GO:0033674 | 0.02212 | 1.37805 | 39 | 52 | 467 | positive regulation of kinase activity |
| GO:0007596 | 0.02234 | 1.69325 | 13 | 21 | 157 | blood coagulation |
| GO:0051099 | 0.02251 | 1.59369 | 17 | 26 | 205 | positive regulation of binding |
| GO:0032989 | 0.02252 | 1.23644 | 96 | 115 | 1142 | cellular component morphogenesis |
| GO:0055082 | 0.02282 | 1.28545 | 66 | 82 | 785 | cellular chemical homeostasis |
| GO:0006937 | 0.02294 | 1.71316 | 12 | 20 | 148 | regulation of muscle contraction |
| GO:0042136 | 0.02294 | 1.88916 | 9 | 15 | 102 | neurotransmitter biosynthetic process |
| GO:0006029 | 0.02296 | 2.15099 | 6 | 11 | 67 | proteoglycan metabolic process |
| GO:0048589 | 0.02374 | 1.28679 | 64 | 80 | 765 | developmental growth |
| GO:0050714 | 0.02376 | 1.48735 | 24 | 34 | 285 | positive regulation of protein secretion |
| GO:0030214 | 0.02396 | 6.55901 | 1 | 3 | 8 | hyaluronan catabolic process |
| GO:0032511 | 0.02396 | 6.55901 | 1 | 3 | 8 | late endosome to vacuole transport via multivesicular body sorting pathway |
| GO:0034475 | 0.02396 | 6.55901 | 1 | 3 | 8 | U4 snRNA 3'-end processing |
| GO:0044650 | 0.02396 | 6.55901 | 1 | 3 | 8 | adhesion of symbiont to host cell |
| GO:0060371 | 0.02396 | 6.55901 | 1 | 3 | 8 | regulation of atrial cardiac muscle cell membrane depolarization |
| GO:0061687 | 0.02396 | 6.55901 | 1 | 3 | 8 | detoxification of inorganic compound |
| GO:0061744 | 0.02396 | 6.55901 | 1 | 3 | 8 | motor behavior |
| GO:0071493 | 0.02396 | 6.55901 | 1 | 3 | 8 | cellular response to UV-B |
| GO:0090527 | 0.02396 | 6.55901 | 1 | 3 | 8 | actin filament reorganization |
| GO:0097368 | 0.02396 | 6.55901 | 1 | 3 | 8 | establishment of Sertoli cell barrier |
| GO:0097501 | 0.02396 | 6.55901 | 1 | 3 | 8 | stress response to metal ion |
| GO:2001269 | 0.02396 | 6.55901 | 1 | 3 | 8 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| GO:0001755 | 0.02398 | 2.23438 | 5 | 10 | 59 | neural crest cell migration |
| GO:0006661 | 0.02398 | 2.23438 | 5 | 10 | 59 | phosphatidylinositol biosynthetic process |
| GO:0032722 | 0.02398 | 2.23438 | 5 | 10 | 59 | positive regulation of chemokine production |
| GO:0050710 | 0.02398 | 2.23438 | 5 | 10 | 59 | negative regulation of cytokine secretion |
| GO:0060986 | 0.02398 | 2.23438 | 5 | 10 | 59 | endocrine hormone secretion |
| GO:0055076 | 0.02399 | 1.76162 | 11 | 18 | 130 | transition metal ion homeostasis |
| GO:0043085 | 0.02420 | 1.24445 | 87 | 105 | 1036 | positive regulation of catalytic activity |
| GO:1900026 | 0.02420 | 2.73559 | 3 | 7 | 35 | positive regulation of substrate adhesion-dependent cell spreading |
| GO:0045597 | 0.02441 | 1.23889 | 91 | 109 | 1080 | positive regulation of cell differentiation |
| GO:0071900 | 0.02444 | 1.39253 | 35 | 47 | 418 | regulation of protein serine/threonine kinase activity |
| GO:0014032 | 0.02453 | 1.97772 | 7 | 13 | 85 | neural crest cell development |
| GO:1904035 | 0.02453 | 1.97772 | 7 | 13 | 85 | regulation of epithelial cell apoptotic process |
| GO:2000117 | 0.02453 | 1.97772 | 7 | 13 | 85 | negative regulation of cysteine-type endopeptidase activity |
| GO:0051338 | 0.02458 | 1.27453 | 69 | 85 | 820 | regulation of transferase activity |
| GO:0045862 | 0.02463 | 1.45649 | 27 | 37 | 316 | positive regulation of proteolysis |
| GO:0090305 | 0.02469 | 1.82635 | 9 | 16 | 112 | nucleic acid phosphodiester bond hydrolysis |
| GO:0042593 | 0.02480 | 1.51232 | 21 | 31 | 256 | glucose homeostasis |
| GO:0030510 | 0.02480 | 1.91714 | 8 | 14 | 94 | regulation of BMP signaling pathway |
| GO:0046916 | 0.02480 | 1.91714 | 8 | 14 | 94 | cellular transition metal ion homeostasis |
| GO:0042771 | 0.02488 | 2.50157 | 4 | 8 | 43 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:0060537 | 0.02494 | 1.37105 | 39 | 51 | 460 | muscle tissue development |
| GO:0010839 | 0.02498 | 4.37390 | 1 | 4 | 14 | negative regulation of keratinocyte proliferation |
| GO:0015682 | 0.02498 | 4.37390 | 1 | 4 | 14 | ferric iron transport |
| GO:0034315 | 0.02498 | 4.37390 | 1 | 4 | 14 | regulation of Arp2/3 complex-mediated actin nucleation |
| GO:0034433 | 0.02498 | 4.37390 | 1 | 4 | 14 | steroid esterification |
| GO:0034434 | 0.02498 | 4.37390 | 1 | 4 | 14 | sterol esterification |
| GO:0034435 | 0.02498 | 4.37390 | 1 | 4 | 14 | cholesterol esterification |
| GO:0034471 | 0.02498 | 4.37390 | 1 | 4 | 14 | ncRNA 5'-end processing |
| GO:0042559 | 0.02498 | 4.37390 | 1 | 4 | 14 | pteridine-containing compound biosynthetic process |
| GO:0046132 | 0.02498 | 4.37390 | 1 | 4 | 14 | pyrimidine ribonucleoside biosynthetic process |
| GO:0046134 | 0.02498 | 4.37390 | 1 | 4 | 14 | pyrimidine nucleoside biosynthetic process |
| GO:0070486 | 0.02498 | 4.37390 | 1 | 4 | 14 | leukocyte aggregation |
| GO:0072512 | 0.02498 | 4.37390 | 1 | 4 | 14 | trivalent inorganic cation transport |
| GO:0090196 | 0.02498 | 4.37390 | 1 | 4 | 14 | regulation of chemokine secretion |
| GO:1901841 | 0.02498 | 4.37390 | 1 | 4 | 14 | regulation of high voltage-gated calcium channel activity |
| GO:2001267 | 0.02498 | 4.37390 | 1 | 4 | 14 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| GO:0007599 | 0.02533 | 1.66855 | 13 | 21 | 159 | hemostasis |
| GO:0007517 | 0.02536 | 1.38872 | 35 | 47 | 419 | muscle organ development |
| GO:0032418 | 0.02539 | 2.11315 | 6 | 11 | 68 | lysosome localization |
| GO:0072594 | 0.02554 | 1.41039 | 32 | 43 | 378 | establishment of protein localization to organelle |
| GO:0060271 | 0.02594 | 1.46681 | 25 | 35 | 297 | cilium assembly |
| GO:0031503 | 0.02594 | 1.51728 | 21 | 30 | 247 | protein-containing complex localization |
| GO:0048534 | 0.02600 | 1.25108 | 80 | 97 | 952 | hematopoietic or lymphoid organ development |
| GO:0033500 | 0.02602 | 1.50556 | 22 | 31 | 257 | carbohydrate homeostasis |
| GO:0051173 | 0.02620 | 1.14462 | 252 | 280 | 3000 | positive regulation of nitrogen compound metabolic process |
| GO:0001945 | 0.02620 | 2.98359 | 2 | 6 | 28 | lymph vessel development |
| GO:0034508 | 0.02620 | 2.98359 | 2 | 6 | 28 | centromere complex assembly |
| GO:2000727 | 0.02620 | 2.98359 | 2 | 6 | 28 | positive regulation of cardiac muscle cell differentiation |
| GO:0002260 | 0.02627 | 2.02181 | 6 | 12 | 77 | lymphocyte homeostasis |
| GO:1904951 | 0.02657 | 1.37408 | 37 | 49 | 441 | positive regulation of establishment of protein localization |
| GO:0043500 | 0.02660 | 1.80744 | 9 | 16 | 113 | muscle adaptation |
| GO:0086003 | 0.02669 | 2.18959 | 5 | 10 | 60 | cardiac muscle cell contraction |
| GO:1905207 | 0.02669 | 2.18959 | 5 | 10 | 60 | regulation of cardiocyte differentiation |
| GO:0010634 | 0.02683 | 1.70715 | 12 | 19 | 141 | positive regulation of epithelial cell migration |
| GO:0006612 | 0.02686 | 1.84653 | 9 | 15 | 104 | protein targeting to membrane |
| GO:0043502 | 0.02692 | 1.89338 | 8 | 14 | 95 | regulation of muscle adaptation |
| GO:0046887 | 0.02693 | 1.65647 | 13 | 21 | 160 | positive regulation of hormone secretion |
| GO:0000469 | 0.02703 | 3.41790 | 2 | 5 | 21 | cleavage involved in rRNA processing |
| GO:0010743 | 0.02703 | 3.41790 | 2 | 5 | 21 | regulation of macrophage derived foam cell differentiation |
| GO:0032332 | 0.02703 | 3.41790 | 2 | 5 | 21 | positive regulation of chondrocyte differentiation |
| GO:0097205 | 0.02703 | 3.41790 | 2 | 5 | 21 | renal filtration |
| GO:0070838 | 0.02714 | 1.36731 | 38 | 50 | 452 | divalent metal ion transport |
| GO:0031325 | 0.02715 | 1.14086 | 262 | 291 | 3128 | positive regulation of cellular metabolic process |
| GO:0051048 | 0.02722 | 1.51025 | 21 | 30 | 248 | negative regulation of secretion |
| GO:0006281 | 0.02753 | 1.37052 | 37 | 49 | 442 | DNA repair |
| GO:0043409 | 0.02763 | 1.62997 | 14 | 22 | 170 | negative regulation of MAPK cascade |
| GO:0030514 | 0.02771 | 2.29100 | 4 | 9 | 52 | negative regulation of BMP signaling pathway |
| GO:0045773 | 0.02771 | 2.29100 | 4 | 9 | 52 | positive regulation of axon extension |
| GO:0071478 | 0.02779 | 1.67369 | 13 | 20 | 151 | cellular response to radiation |
| GO:0061384 | 0.02793 | 2.64113 | 3 | 7 | 36 | heart trabecula morphogenesis |
| GO:0045669 | 0.02799 | 2.07662 | 6 | 11 | 69 | positive regulation of osteoblast differentiation |
| GO:0048146 | 0.02799 | 2.07662 | 6 | 11 | 69 | positive regulation of fibroblast proliferation |
| GO:1901796 | 0.02799 | 2.07662 | 6 | 11 | 69 | regulation of signal transduction by p53 class mediator |
| GO:0030097 | 0.02815 | 1.25350 | 76 | 92 | 901 | hemopoiesis |
| GO:0090184 | 0.02824 | 2.43197 | 4 | 8 | 44 | positive regulation of kidney development |
| GO:0007178 | 0.02845 | 1.41726 | 29 | 40 | 350 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0050817 | 0.02861 | 1.64456 | 14 | 21 | 161 | coagulation |
| GO:0032269 | 0.02883 | 1.24039 | 83 | 100 | 989 | negative regulation of cellular protein metabolic process |
| GO:0048661 | 0.02899 | 1.82593 | 9 | 15 | 105 | positive regulation of smooth muscle cell proliferation |
| GO:2000379 | 0.02899 | 1.82593 | 9 | 15 | 105 | positive regulation of reactive oxygen species metabolic process |
| GO:0000041 | 0.02912 | 1.92409 | 7 | 13 | 87 | transition metal ion transport |
| GO:0032602 | 0.02912 | 1.92409 | 7 | 13 | 87 | chemokine production |
| GO:1905954 | 0.02912 | 1.92409 | 7 | 13 | 87 | positive regulation of lipid localization |
| GO:0010876 | 0.02930 | 1.40736 | 30 | 41 | 361 | lipid localization |
| GO:0030595 | 0.02939 | 1.55001 | 18 | 26 | 210 | leukocyte chemotaxis |
| GO:0043900 | 0.02941 | 1.38915 | 33 | 44 | 392 | regulation of multi-organism process |
| GO:0015914 | 0.02961 | 2.14655 | 5 | 10 | 61 | phospholipid transport |
| GO:0030858 | 0.02961 | 2.14655 | 5 | 10 | 61 | positive regulation of epithelial cell differentiation |
| GO:0032677 | 0.02961 | 2.14655 | 5 | 10 | 61 | regulation of interleukin-8 production |
| GO:0055002 | 0.02985 | 1.59628 | 15 | 23 | 181 | striated muscle cell development |
| GO:0072511 | 0.03012 | 1.35699 | 38 | 50 | 455 | divalent inorganic cation transport |
| GO:0006888 | 0.03013 | 1.74101 | 10 | 17 | 124 | ER to Golgi vesicle-mediated transport |
| GO:0016197 | 0.03031 | 1.57606 | 16 | 24 | 191 | endosomal transport |
| GO:0046039 | 0.03076 | 2.85373 | 2 | 6 | 29 | GTP metabolic process |
| GO:0099622 | 0.03076 | 2.85373 | 2 | 6 | 29 | cardiac muscle cell membrane repolarization |
| GO:0002532 | 0.03078 | 2.04133 | 6 | 11 | 70 | production of molecular mediator involved in inflammatory response |
| GO:0006094 | 0.03078 | 2.04133 | 6 | 11 | 70 | gluconeogenesis |
| GO:0010611 | 0.03078 | 2.04133 | 6 | 11 | 70 | regulation of cardiac muscle hypertrophy |
| GO:0030336 | 0.03134 | 1.47910 | 22 | 31 | 261 | negative regulation of cell migration |
| GO:0006942 | 0.03142 | 1.96128 | 7 | 12 | 79 | regulation of striated muscle contraction |
| GO:0015748 | 0.03142 | 1.96128 | 7 | 12 | 79 | organophosphate ester transport |
| GO:0051341 | 0.03142 | 1.96128 | 7 | 12 | 79 | regulation of oxidoreductase activity |
| GO:0038061 | 0.03156 | 1.84758 | 8 | 14 | 97 | NIK/NF-kappaB signaling |
| GO:0045638 | 0.03156 | 1.84758 | 8 | 14 | 97 | negative regulation of myeloid cell differentiation |
| GO:0009887 | 0.03182 | 1.22789 | 88 | 105 | 1048 | animal organ morphogenesis |
| GO:0000212 | 0.03185 | 3.97608 | 1 | 4 | 15 | meiotic spindle organization |
| GO:0000291 | 0.03185 | 3.97608 | 1 | 4 | 15 | nuclear-transcribed mRNA catabolic process, exonucleolytic |
| GO:0009220 | 0.03185 | 3.97608 | 1 | 4 | 15 | pyrimidine ribonucleotide biosynthetic process |
| GO:0042407 | 0.03185 | 3.97608 | 1 | 4 | 15 | cristae formation |
| GO:0060192 | 0.03185 | 3.97608 | 1 | 4 | 15 | negative regulation of lipase activity |
| GO:0060347 | 0.03185 | 3.97608 | 1 | 4 | 15 | heart trabecula formation |
| GO:0060442 | 0.03185 | 3.97608 | 1 | 4 | 15 | branching involved in prostate gland morphogenesis |
| GO:0061051 | 0.03185 | 3.97608 | 1 | 4 | 15 | positive regulation of cell growth involved in cardiac muscle cell development |
| GO:0072109 | 0.03185 | 3.97608 | 1 | 4 | 15 | glomerular mesangium development |
| GO:0090195 | 0.03185 | 3.97608 | 1 | 4 | 15 | chemokine secretion |
| GO:0097286 | 0.03185 | 3.97608 | 1 | 4 | 15 | iron ion import |
| GO:1900037 | 0.03185 | 3.97608 | 1 | 4 | 15 | regulation of cellular response to hypoxia |
| GO:0003254 | 0.03191 | 2.36613 | 4 | 8 | 45 | regulation of membrane depolarization |
| GO:0048265 | 0.03204 | 2.55298 | 3 | 7 | 37 | response to pain |
| GO:1905209 | 0.03204 | 2.55298 | 3 | 7 | 37 | positive regulation of cardiocyte differentiation |
| GO:0045807 | 0.03220 | 1.62124 | 14 | 21 | 163 | positive regulation of endocytosis |
| GO:0022411 | 0.03234 | 1.40877 | 29 | 39 | 343 | cellular component disassembly |
| GO:0033043 | 0.03256 | 1.21048 | 102 | 120 | 1214 | regulation of organelle organization |
| GO:0034505 | 0.03264 | 3.21669 | 2 | 5 | 22 | tooth mineralization |
| GO:0043567 | 0.03264 | 3.21669 | 2 | 5 | 22 | regulation of insulin-like growth factor receptor signaling pathway |
| GO:0010769 | 0.03267 | 1.41439 | 28 | 38 | 333 | regulation of cell morphogenesis involved in differentiation |
| GO:1903522 | 0.03283 | 1.50573 | 19 | 28 | 232 | regulation of blood circulation |
| GO:0050801 | 0.03296 | 1.25949 | 67 | 82 | 799 | ion homeostasis |
| GO:0006869 | 0.03297 | 1.42037 | 27 | 37 | 323 | lipid transport |
| GO:0043549 | 0.03322 | 1.27473 | 60 | 74 | 713 | regulation of kinase activity |
| GO:0048872 | 0.03326 | 1.42675 | 26 | 36 | 313 | homeostasis of number of cells |
| GO:0009162 | 0.03373 | 5.46559 | 1 | 3 | 9 | deoxyribonucleoside monophosphate metabolic process |
| GO:0009396 | 0.03373 | 5.46559 | 1 | 3 | 9 | folic acid-containing compound biosynthetic process |
| GO:0016559 | 0.03373 | 5.46559 | 1 | 3 | 9 | peroxisome fission |
| GO:0034374 | 0.03373 | 5.46559 | 1 | 3 | 9 | low-density lipoprotein particle remodeling |
| GO:0036363 | 0.03373 | 5.46559 | 1 | 3 | 9 | transforming growth factor beta activation |
| GO:0042182 | 0.03373 | 5.46559 | 1 | 3 | 9 | ketone catabolic process |
| GO:0043569 | 0.03373 | 5.46559 | 1 | 3 | 9 | negative regulation of insulin-like growth factor receptor signaling pathway |
| GO:0060426 | 0.03373 | 5.46559 | 1 | 3 | 9 | lung vasculature development |
| GO:0045453 | 0.03377 | 2.00721 | 6 | 11 | 71 | bone resorption |
| GO:0030001 | 0.03408 | 1.25356 | 69 | 84 | 822 | metal ion transport |
| GO:0055024 | 0.03409 | 1.82550 | 8 | 14 | 98 | regulation of cardiac muscle tissue development |
| GO:0001938 | 0.03432 | 1.87328 | 7 | 13 | 89 | positive regulation of endothelial cell proliferation |
| GO:0044060 | 0.03451 | 2.18897 | 5 | 9 | 54 | regulation of endocrine process |
| GO:0002262 | 0.03472 | 1.58678 | 15 | 22 | 174 | myeloid cell homeostasis |
| GO:0009411 | 0.03571 | 1.67157 | 11 | 18 | 136 | response to UV |
| GO:0050921 | 0.03571 | 1.67157 | 11 | 18 | 136 | positive regulation of chemotaxis |
| GO:0019884 | 0.03581 | 2.73470 | 3 | 6 | 30 | antigen processing and presentation of exogenous antigen |
| GO:0044319 | 0.03581 | 2.73470 | 3 | 6 | 30 | wound healing, spreading of cells |
| GO:0090505 | 0.03581 | 2.73470 | 3 | 6 | 30 | epiboly involved in wound healing |
| GO:0043388 | 0.03610 | 2.06536 | 5 | 10 | 63 | positive regulation of DNA binding |
| GO:1901264 | 0.03610 | 2.06536 | 5 | 10 | 63 | carbohydrate derivative transport |
| GO:0051262 | 0.03612 | 1.59857 | 14 | 21 | 165 | protein tetramerization |
| GO:0045596 | 0.03613 | 1.25645 | 66 | 80 | 781 | negative regulation of cell differentiation |
| GO:0030282 | 0.03614 | 1.76678 | 9 | 15 | 108 | bone mineralization |
| GO:0044282 | 0.03641 | 1.42281 | 26 | 35 | 305 | small molecule catabolic process |
| GO:0033628 | 0.03652 | 2.47051 | 3 | 7 | 38 | regulation of cell adhesion mediated by integrin |
| GO:0043267 | 0.03652 | 2.47051 | 3 | 7 | 38 | negative regulation of potassium ion transport |
| GO:0070884 | 0.03652 | 2.47051 | 3 | 7 | 38 | regulation of calcineurin-NFAT signaling cascade |
| GO:0086004 | 0.03652 | 2.47051 | 3 | 7 | 38 | regulation of cardiac muscle cell contraction |
| GO:0106056 | 0.03652 | 2.47051 | 3 | 7 | 38 | regulation of calcineurin-mediated signaling |
| GO:0014743 | 0.03695 | 1.97421 | 6 | 11 | 72 | regulation of muscle hypertrophy |
| GO:0014031 | 0.03715 | 1.84886 | 8 | 13 | 90 | mesenchymal cell development |
| GO:0050900 | 0.03715 | 1.40543 | 27 | 37 | 326 | leukocyte migration |
| GO:0071496 | 0.03724 | 1.44499 | 23 | 32 | 275 | cellular response to external stimulus |
| GO:0030203 | 0.03725 | 1.90425 | 7 | 12 | 81 | glycosaminoglycan metabolic process |
| GO:1903321 | 0.03725 | 1.90425 | 7 | 12 | 81 | negative regulation of protein modification by small protein conjugation or removal |
| GO:0000480 | 0.03765 | 10.92762 | 0 | 2 | 4 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO:0001923 | 0.03765 | 10.92762 | 0 | 2 | 4 | B-1 B cell differentiation |
| GO:0002188 | 0.03765 | 10.92762 | 0 | 2 | 4 | translation reinitiation |
| GO:0002351 | 0.03765 | 10.92762 | 0 | 2 | 4 | serotonin production involved in inflammatory response |
| GO:0002442 | 0.03765 | 10.92762 | 0 | 2 | 4 | serotonin secretion involved in inflammatory response |
| GO:0002538 | 0.03765 | 10.92762 | 0 | 2 | 4 | arachidonic acid metabolite production involved in inflammatory response |
| GO:0006244 | 0.03765 | 10.92762 | 0 | 2 | 4 | pyrimidine nucleotide catabolic process |
| GO:0006578 | 0.03765 | 10.92762 | 0 | 2 | 4 | amino-acid betaine biosynthetic process |
| GO:0006710 | 0.03765 | 10.92762 | 0 | 2 | 4 | androgen catabolic process |
| GO:0006931 | 0.03765 | 10.92762 | 0 | 2 | 4 | substrate-dependent cell migration, cell attachment to substrate |
| GO:0009223 | 0.03765 | 10.92762 | 0 | 2 | 4 | pyrimidine deoxyribonucleotide catabolic process |
| GO:0009826 | 0.03765 | 10.92762 | 0 | 2 | 4 | unidimensional cell growth |
| GO:0010730 | 0.03765 | 10.92762 | 0 | 2 | 4 | negative regulation of hydrogen peroxide biosynthetic process |
| GO:0015734 | 0.03765 | 10.92762 | 0 | 2 | 4 | taurine transport |
| GO:0021886 | 0.03765 | 10.92762 | 0 | 2 | 4 | hypothalamus gonadotrophin-releasing hormone neuron differentiation |
| GO:0021888 | 0.03765 | 10.92762 | 0 | 2 | 4 | hypothalamus gonadotrophin-releasing hormone neuron development |
| GO:0030167 | 0.03765 | 10.92762 | 0 | 2 | 4 | proteoglycan catabolic process |
| GO:0033540 | 0.03765 | 10.92762 | 0 | 2 | 4 | fatty acid beta-oxidation using acyl-CoA oxidase |
| GO:0034552 | 0.03765 | 10.92762 | 0 | 2 | 4 | respiratory chain complex II assembly |
| GO:0034553 | 0.03765 | 10.92762 | 0 | 2 | 4 | mitochondrial respiratory chain complex II assembly |
| GO:0035583 | 0.03765 | 10.92762 | 0 | 2 | 4 | sequestering of TGFbeta in extracellular matrix |
| GO:0035788 | 0.03765 | 10.92762 | 0 | 2 | 4 | cell migration involved in metanephros development |
| GO:0035789 | 0.03765 | 10.92762 | 0 | 2 | 4 | metanephric mesenchymal cell migration |
| GO:0038095 | 0.03765 | 10.92762 | 0 | 2 | 4 | Fc-epsilon receptor signaling pathway |
| GO:0038156 | 0.03765 | 10.92762 | 0 | 2 | 4 | interleukin-3-mediated signaling pathway |
| GO:0042494 | 0.03765 | 10.92762 | 0 | 2 | 4 | detection of bacterial lipoprotein |
| GO:0042776 | 0.03765 | 10.92762 | 0 | 2 | 4 | mitochondrial ATP synthesis coupled proton transport |
| GO:0043328 | 0.03765 | 10.92762 | 0 | 2 | 4 | protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
| GO:0046351 | 0.03765 | 10.92762 | 0 | 2 | 4 | disaccharide biosynthetic process |
| GO:0060279 | 0.03765 | 10.92762 | 0 | 2 | 4 | positive regulation of ovulation |
| GO:0060686 | 0.03765 | 10.92762 | 0 | 2 | 4 | negative regulation of prostatic bud formation |
| GO:0061181 | 0.03765 | 10.92762 | 0 | 2 | 4 | regulation of chondrocyte development |
| GO:0061622 | 0.03765 | 10.92762 | 0 | 2 | 4 | glycolytic process through glucose-1-phosphate |
| GO:0071072 | 0.03765 | 10.92762 | 0 | 2 | 4 | negative regulation of phospholipid biosynthetic process |
| GO:0071724 | 0.03765 | 10.92762 | 0 | 2 | 4 | response to diacyl bacterial lipopeptide |
| GO:0071726 | 0.03765 | 10.92762 | 0 | 2 | 4 | cellular response to diacyl bacterial lipopeptide |
| GO:0086017 | 0.03765 | 10.92762 | 0 | 2 | 4 | Purkinje myocyte action potential |
| GO:0090187 | 0.03765 | 10.92762 | 0 | 2 | 4 | positive regulation of pancreatic juice secretion |
| GO:0099183 | 0.03765 | 10.92762 | 0 | 2 | 4 | trans-synaptic signaling by BDNF, modulating synaptic transmission |
| GO:0099191 | 0.03765 | 10.92762 | 0 | 2 | 4 | trans-synaptic signaling by BDNF |
| GO:0099538 | 0.03765 | 10.92762 | 0 | 2 | 4 | synaptic signaling via neuropeptide |
| GO:0140192 | 0.03765 | 10.92762 | 0 | 2 | 4 | regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process |
| GO:1900108 | 0.03765 | 10.92762 | 0 | 2 | 4 | negative regulation of nodal signaling pathway |
| GO:1901509 | 0.03765 | 10.92762 | 0 | 2 | 4 | regulation of endothelial tube morphogenesis |
| GO:1902463 | 0.03765 | 10.92762 | 0 | 2 | 4 | protein localization to cell leading edge |
| GO:1902512 | 0.03765 | 10.92762 | 0 | 2 | 4 | positive regulation of apoptotic DNA fragmentation |
| GO:1902730 | 0.03765 | 10.92762 | 0 | 2 | 4 | positive regulation of proteoglycan biosynthetic process |
| GO:1902897 | 0.03765 | 10.92762 | 0 | 2 | 4 | regulation of postsynaptic density protein 95 clustering |
| GO:2000097 | 0.03765 | 10.92762 | 0 | 2 | 4 | regulation of smooth muscle cell-matrix adhesion |
| GO:2000589 | 0.03765 | 10.92762 | 0 | 2 | 4 | regulation of metanephric mesenchymal cell migration |
| GO:2001199 | 0.03765 | 10.92762 | 0 | 2 | 4 | negative regulation of dendritic cell differentiation |
| GO:0017038 | 0.03784 | 1.49560 | 19 | 27 | 225 | protein import |
| GO:0002526 | 0.03785 | 1.71843 | 10 | 16 | 118 | acute inflammatory response |
| GO:0046173 | 0.03831 | 2.14129 | 5 | 9 | 55 | polyol biosynthetic process |
| GO:0050922 | 0.03831 | 2.14129 | 5 | 9 | 55 | negative regulation of chemotaxis |
| GO:0010770 | 0.03873 | 1.56602 | 15 | 22 | 176 | positive regulation of cell morphogenesis involved in differentiation |
| GO:0002827 | 0.03891 | 3.03785 | 2 | 5 | 23 | positive regulation of T-helper 1 type immune response |
| GO:0032928 | 0.03891 | 3.03785 | 2 | 5 | 23 | regulation of superoxide anion generation |
| GO:0070168 | 0.03891 | 3.03785 | 2 | 5 | 23 | negative regulation of biomineral tissue development |
| GO:2000831 | 0.03891 | 3.03785 | 2 | 5 | 23 | regulation of steroid hormone secretion |
| GO:0030593 | 0.03957 | 1.78288 | 8 | 14 | 100 | neutrophil chemotaxis |
| GO:0000463 | 0.03973 | 3.64457 | 1 | 4 | 16 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO:0000966 | 0.03973 | 3.64457 | 1 | 4 | 16 | RNA 5'-end processing |
| GO:0002283 | 0.03973 | 3.64457 | 1 | 4 | 16 | neutrophil activation involved in immune response |
| GO:0006878 | 0.03973 | 3.64457 | 1 | 4 | 16 | cellular copper ion homeostasis |
| GO:0006968 | 0.03973 | 3.64457 | 1 | 4 | 16 | cellular defense response |
| GO:0009218 | 0.03973 | 3.64457 | 1 | 4 | 16 | pyrimidine ribonucleotide metabolic process |
| GO:0010752 | 0.03973 | 3.64457 | 1 | 4 | 16 | regulation of cGMP-mediated signaling |
| GO:0032957 | 0.03973 | 3.64457 | 1 | 4 | 16 | inositol trisphosphate metabolic process |
| GO:0034134 | 0.03973 | 3.64457 | 1 | 4 | 16 | toll-like receptor 2 signaling pathway |
| GO:0034349 | 0.03973 | 3.64457 | 1 | 4 | 16 | glial cell apoptotic process |
| GO:0036035 | 0.03973 | 3.64457 | 1 | 4 | 16 | osteoclast development |
| GO:0071071 | 0.03973 | 3.64457 | 1 | 4 | 16 | regulation of phospholipid biosynthetic process |
| GO:0090128 | 0.03973 | 3.64457 | 1 | 4 | 16 | regulation of synapse maturation |
| GO:0090192 | 0.03973 | 3.64457 | 1 | 4 | 16 | regulation of glomerulus development |
| GO:1900746 | 0.03973 | 3.64457 | 1 | 4 | 16 | regulation of vascular endothelial growth factor signaling pathway |
| GO:1902337 | 0.03973 | 3.64457 | 1 | 4 | 16 | regulation of apoptotic process involved in morphogenesis |
| GO:0034765 | 0.03999 | 1.33250 | 38 | 49 | 453 | regulation of ion transmembrane transport |
| GO:1903532 | 0.03999 | 1.33250 | 38 | 49 | 453 | positive regulation of secretion by cell |
| GO:0002028 | 0.04014 | 1.82507 | 8 | 13 | 91 | regulation of sodium ion transport |
| GO:0006111 | 0.04019 | 2.24458 | 4 | 8 | 47 | regulation of gluconeogenesis |
| GO:0051353 | 0.04019 | 2.24458 | 4 | 8 | 47 | positive regulation of oxidoreductase activity |
| GO:0051489 | 0.04019 | 2.24458 | 4 | 8 | 47 | regulation of filopodium assembly |
| GO:0006066 | 0.04021 | 1.42561 | 24 | 33 | 287 | alcohol metabolic process |
| GO:1902105 | 0.04021 | 1.42561 | 24 | 33 | 287 | regulation of leukocyte differentiation |
| GO:0051899 | 0.04044 | 1.87696 | 7 | 12 | 82 | membrane depolarization |
| GO:0001659 | 0.04086 | 1.55584 | 15 | 22 | 177 | temperature homeostasis |
| GO:0034314 | 0.04136 | 2.62519 | 3 | 6 | 31 | Arp2/3 complex-mediated actin nucleation |
| GO:0050999 | 0.04136 | 2.62519 | 3 | 6 | 31 | regulation of nitric-oxide synthase activity |
| GO:0090504 | 0.04136 | 2.62519 | 3 | 6 | 31 | epiboly |
| GO:0098884 | 0.04136 | 2.62519 | 3 | 6 | 31 | postsynaptic neurotransmitter receptor internalization |
| GO:0140239 | 0.04136 | 2.62519 | 3 | 6 | 31 | postsynaptic endocytosis |
| GO:2000352 | 0.04136 | 2.62519 | 3 | 6 | 31 | negative regulation of endothelial cell apoptotic process |
| GO:0003298 | 0.04141 | 2.39319 | 3 | 7 | 39 | physiological muscle hypertrophy |
| GO:0003301 | 0.04141 | 2.39319 | 3 | 7 | 39 | physiological cardiac muscle hypertrophy |
| GO:0061049 | 0.04141 | 2.39319 | 3 | 7 | 39 | cell growth involved in cardiac muscle cell development |
| GO:2000008 | 0.04141 | 2.39319 | 3 | 7 | 39 | regulation of protein localization to cell surface |
| GO:0034764 | 0.04160 | 1.49271 | 18 | 26 | 217 | positive regulation of transmembrane transport |
| GO:0010556 | 0.04221 | 1.12405 | 272 | 298 | 3242 | regulation of macromolecule biosynthetic process |
| GO:0032720 | 0.04238 | 2.09563 | 5 | 9 | 56 | negative regulation of tumor necrosis factor production |
| GO:0002520 | 0.04309 | 1.21470 | 84 | 100 | 1007 | immune system development |
| GO:0014065 | 0.04319 | 1.68523 | 10 | 16 | 120 | phosphatidylinositol 3-kinase signaling |
| GO:0014033 | 0.04330 | 1.80189 | 8 | 13 | 92 | neural crest cell differentiation |
| GO:0097529 | 0.04354 | 1.51216 | 17 | 24 | 198 | myeloid leukocyte migration |
| GO:0007044 | 0.04381 | 1.85043 | 7 | 12 | 83 | cell-substrate junction assembly |
| GO:0034103 | 0.04381 | 1.85043 | 7 | 12 | 83 | regulation of tissue remodeling |
| GO:1903169 | 0.04382 | 1.60149 | 13 | 19 | 149 | regulation of calcium ion transmembrane transport |
| GO:0055021 | 0.04393 | 1.91136 | 6 | 11 | 74 | regulation of cardiac muscle tissue growth |
| GO:0060350 | 0.04393 | 1.91136 | 6 | 11 | 74 | endochondral bone morphogenesis |
| GO:0071347 | 0.04393 | 1.91136 | 6 | 11 | 74 | cellular response to interleukin-1 |
| GO:0071495 | 0.04408 | 1.19476 | 101 | 118 | 1207 | cellular response to endogenous stimulus |
| GO:0009057 | 0.04431 | 1.19719 | 99 | 115 | 1174 | macromolecule catabolic process |
| GO:0051282 | 0.04448 | 1.71132 | 9 | 15 | 111 | regulation of sequestering of calcium ion |
| GO:0002720 | 0.04482 | 2.18836 | 4 | 8 | 48 | positive regulation of cytokine production involved in immune response |
| GO:0010862 | 0.04482 | 2.18836 | 4 | 8 | 48 | positive regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0006012 | 0.04524 | 4.68457 | 1 | 3 | 10 | galactose metabolic process |
| GO:0006995 | 0.04524 | 4.68457 | 1 | 3 | 10 | cellular response to nitrogen starvation |
| GO:0009221 | 0.04524 | 4.68457 | 1 | 3 | 10 | pyrimidine deoxyribonucleotide biosynthetic process |
| GO:0009650 | 0.04524 | 4.68457 | 1 | 3 | 10 | UV protection |
| GO:0033572 | 0.04524 | 4.68457 | 1 | 3 | 10 | transferrin transport |
| GO:0034427 | 0.04524 | 4.68457 | 1 | 3 | 10 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' |
| GO:0035744 | 0.04524 | 4.68457 | 1 | 3 | 10 | T-helper 1 cell cytokine production |
| GO:0043173 | 0.04524 | 4.68457 | 1 | 3 | 10 | nucleotide salvage |
| GO:0043562 | 0.04524 | 4.68457 | 1 | 3 | 10 | cellular response to nitrogen levels |
| GO:0046485 | 0.04524 | 4.68457 | 1 | 3 | 10 | ether lipid metabolic process |
| GO:0055091 | 0.04524 | 4.68457 | 1 | 3 | 10 | phospholipid homeostasis |
| GO:0070391 | 0.04524 | 4.68457 | 1 | 3 | 10 | response to lipoteichoic acid |
| GO:0071223 | 0.04524 | 4.68457 | 1 | 3 | 10 | cellular response to lipoteichoic acid |
| GO:1900038 | 0.04524 | 4.68457 | 1 | 3 | 10 | negative regulation of cellular response to hypoxia |
| GO:1903431 | 0.04524 | 4.68457 | 1 | 3 | 10 | positive regulation of cell maturation |
| GO:0031334 | 0.04535 | 1.45530 | 20 | 28 | 239 | positive regulation of protein complex assembly |
| GO:0051347 | 0.04539 | 1.29160 | 45 | 57 | 542 | positive regulation of transferase activity |
| GO:0045017 | 0.04556 | 1.61646 | 12 | 18 | 140 | glycerolipid biosynthetic process |
| GO:0006650 | 0.04569 | 1.47710 | 18 | 26 | 219 | glycerophospholipid metabolic process |
| GO:0001516 | 0.04587 | 2.87782 | 2 | 5 | 24 | prostaglandin biosynthetic process |
| GO:0006882 | 0.04587 | 2.87782 | 2 | 5 | 24 | cellular zinc ion homeostasis |
| GO:0032770 | 0.04587 | 2.87782 | 2 | 5 | 24 | positive regulation of monooxygenase activity |
| GO:0044342 | 0.04587 | 2.87782 | 2 | 5 | 24 | type B pancreatic cell proliferation |
| GO:0046457 | 0.04587 | 2.87782 | 2 | 5 | 24 | prostanoid biosynthetic process |
| GO:0048266 | 0.04587 | 2.87782 | 2 | 5 | 24 | behavioral response to pain |
| GO:0051882 | 0.04587 | 2.87782 | 2 | 5 | 24 | mitochondrial depolarization |
| GO:0090023 | 0.04587 | 2.87782 | 2 | 5 | 24 | positive regulation of neutrophil chemotaxis |
| GO:1905809 | 0.04587 | 2.87782 | 2 | 5 | 24 | negative regulation of synapse organization |
| GO:1901565 | 0.04651 | 1.19999 | 93 | 109 | 1110 | organonitrogen compound catabolic process |
| GO:0010468 | 0.04656 | 1.11326 | 316 | 343 | 3768 | regulation of gene expression |
| GO:0045823 | 0.04670 | 2.32056 | 3 | 7 | 40 | positive regulation of heart contraction |
| GO:1903556 | 0.04673 | 2.05187 | 5 | 9 | 57 | negative regulation of tumor necrosis factor superfamily cytokine production |
| GO:0018209 | 0.04734 | 1.38126 | 27 | 36 | 322 | peptidyl-serine modification |
| GO:0042554 | 0.04742 | 2.52410 | 3 | 6 | 32 | superoxide anion generation |
| GO:0042558 | 0.04742 | 2.52410 | 3 | 6 | 32 | pteridine-containing compound metabolic process |
| GO:0045047 | 0.04742 | 2.52410 | 3 | 6 | 32 | protein targeting to ER |
| GO:0060306 | 0.04742 | 2.52410 | 3 | 6 | 32 | regulation of membrane repolarization |
| GO:0060561 | 0.04742 | 2.52410 | 3 | 6 | 32 | apoptotic process involved in morphogenesis |
| GO:0043902 | 0.04746 | 1.54456 | 14 | 21 | 170 | positive regulation of multi-organism process |
| GO:0042476 | 0.04754 | 1.69360 | 9 | 15 | 112 | odontogenesis |
| GO:0051208 | 0.04754 | 1.69360 | 9 | 15 | 112 | sequestering of calcium ion |
| GO:0071346 | 0.04754 | 1.69360 | 9 | 15 | 112 | cellular response to interferon-gamma |
| GO:0006919 | 0.04774 | 1.88141 | 6 | 11 | 75 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0030500 | 0.04774 | 1.88141 | 6 | 11 | 75 | regulation of bone mineralization |
| GO:0002700 | 0.04830 | 1.60324 | 12 | 18 | 141 | regulation of production of molecular mediator of immune response |
| GO:0055007 | 0.04830 | 1.60324 | 12 | 18 | 141 | cardiac muscle cell differentiation |
| GO:0106106 | 0.04830 | 1.60324 | 12 | 18 | 141 | cold-induced thermogenesis |
| GO:0120161 | 0.04830 | 1.60324 | 12 | 18 | 141 | regulation of cold-induced thermogenesis |
| GO:0021854 | 0.04860 | 3.36406 | 1 | 4 | 17 | hypothalamus development |
| GO:0032691 | 0.04860 | 3.36406 | 1 | 4 | 17 | negative regulation of interleukin-1 beta production |
| GO:0045579 | 0.04860 | 3.36406 | 1 | 4 | 17 | positive regulation of B cell differentiation |
| GO:0045653 | 0.04860 | 3.36406 | 1 | 4 | 17 | negative regulation of megakaryocyte differentiation |
| GO:0051000 | 0.04860 | 3.36406 | 1 | 4 | 17 | positive regulation of nitric-oxide synthase activity |
| GO:0055070 | 0.04860 | 3.36406 | 1 | 4 | 17 | copper ion homeostasis |
| GO:0061081 | 0.04860 | 3.36406 | 1 | 4 | 17 | positive regulation of myeloid leukocyte cytokine production involved in immune response |
| GO:1902176 | 0.04860 | 3.36406 | 1 | 4 | 17 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
| GO:1904748 | 0.04860 | 3.36406 | 1 | 4 | 17 | regulation of apoptotic process involved in development |
| GO:0055006 | 0.04892 | 1.72254 | 9 | 14 | 103 | cardiac cell development |
| GO:0046165 | 0.04905 | 1.65328 | 10 | 16 | 122 | alcohol biosynthetic process |
| GO:0008285 | 0.04909 | 1.25412 | 57 | 69 | 674 | negative regulation of cell proliferation |
| GO:0010466 | 0.04950 | 1.44150 | 20 | 28 | 241 | negative regulation of peptidase activity |
| GO:0045861 | 0.04951 | 1.36283 | 29 | 38 | 344 | negative regulation of proteolysis |
| GO:0023061 | 0.04958 | 1.29250 | 43 | 54 | 513 | signal release |